US20030100018A1 - Mass-based encoding and qualitative analysis of combinatorial libraries - Google Patents
Mass-based encoding and qualitative analysis of combinatorial libraries Download PDFInfo
- Publication number
- US20030100018A1 US20030100018A1 US10/172,525 US17252502A US2003100018A1 US 20030100018 A1 US20030100018 A1 US 20030100018A1 US 17252502 A US17252502 A US 17252502A US 2003100018 A1 US2003100018 A1 US 2003100018A1
- Authority
- US
- United States
- Prior art keywords
- unique
- mass
- chemical
- agent
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 CCCC(C(C1)C2C)C(CCC(C)C)(CC3)*1[C@@]2[C@](C)C(C(C)C)C3(CCC)c1ccc(CI2CI(CCC3ICCC3CCI3CI(CCCC4=CCC(C)C4*(C)=C4ICIC4)CC3)CC2)cc1 Chemical compound CCCC(C(C1)C2C)C(CCC(C)C)(CC3)*1[C@@]2[C@](C)C(C(C)C)C3(CCC)c1ccc(CI2CI(CCC3ICCC3CCI3CI(CCCC4=CCC(C)C4*(C)=C4ICIC4)CC3)CC2)cc1 0.000 description 12
- KPLPZQRHLWWOTL-UHFFFAOYSA-N CC(=O)NCOCCOCCOCC1=CC=C(C)C=C1 Chemical compound CC(=O)NCOCCOCCOCC1=CC=C(C)C=C1 KPLPZQRHLWWOTL-UHFFFAOYSA-N 0.000 description 4
- NHLPSCSHKLRRKI-UHFFFAOYSA-N *.*.*.B.C.C1CC2C1C1C3CCC3C21.C1CCC1.C1CCC1.CC.CC Chemical compound *.*.*.B.C.C1CC2C1C1C3CCC3C21.C1CCC1.C1CCC1.CC.CC NHLPSCSHKLRRKI-UHFFFAOYSA-N 0.000 description 1
- OXEFIYQQNGWZOG-UHFFFAOYSA-N B.BB.C.C.C.C.C.C.C#C.C#C.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC1=CC=CC=C1 Chemical compound B.BB.C.C.C.C.C.C.C#C.C#C.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC1=CC=CC=C1 OXEFIYQQNGWZOG-UHFFFAOYSA-N 0.000 description 1
- JNLBGWXOHUVVCN-UHFFFAOYSA-N C.C.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CCC.CCC.CCC.CCC.CCC.CCC Chemical compound C.C.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CCC.CCC.CCC.CCC.CCC.CCC JNLBGWXOHUVVCN-UHFFFAOYSA-N 0.000 description 1
- NPRQDEYUVVAZDV-MNYXATJNSA-N C.C=CCOC(=O)C(C(=O)CCC(=O)O)=P(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1.C=CCOC(=O)C(C(=O)CCC=O)=P(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1.COC1=CC=C(C(C)C2=CC=C(OCC(=O)NCC3=CC=C(C)C=C3)C=C2)C(OC)=C1.COC1=CC=C(C(C)C2=CC=C(OCC(=O)NCC3=CC=C(C)C=C3)C=C2)C(OC)=C1.COC1=CC=C(C(C)C2=CC=C(OCC(=O)NCC3=CC=C(C)C=C3)C=C2)C(OC)=C1.O.O=C(O)C1=CC=C(CBr)C=C1.O=CC1=CC=C(CBr)C=C1.O=COCC1C2=CC=CC=C2C2=C1/C=C\C=C/2.[3H]F Chemical compound C.C=CCOC(=O)C(C(=O)CCC(=O)O)=P(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1.C=CCOC(=O)C(C(=O)CCC=O)=P(C1=CC=CC=C1)(C1=CC=CC=C1)C1=CC=CC=C1.COC1=CC=C(C(C)C2=CC=C(OCC(=O)NCC3=CC=C(C)C=C3)C=C2)C(OC)=C1.COC1=CC=C(C(C)C2=CC=C(OCC(=O)NCC3=CC=C(C)C=C3)C=C2)C(OC)=C1.COC1=CC=C(C(C)C2=CC=C(OCC(=O)NCC3=CC=C(C)C=C3)C=C2)C(OC)=C1.O.O=C(O)C1=CC=C(CBr)C=C1.O=CC1=CC=C(CBr)C=C1.O=COCC1C2=CC=CC=C2C2=C1/C=C\C=C/2.[3H]F NPRQDEYUVVAZDV-MNYXATJNSA-N 0.000 description 1
- GMOOYOPDPCKCHO-LQRYGBJHSA-N C.C[C@H](N)[13C](=O)O.C[C@H]([16NH2])C(=O)O.NCC(=O)O.O=C(O)CNC(=O)OCC1C2=C(C=CC=C2)C2=C1C=CC=C2.O=C(OCC1C2=C(C=CC=C2)C2=C1C=CC=C2)ON1C(=O)CCC1=O.[2H]C([2H])([2H])[C@@]([2H])(N)[13C](=O)O Chemical compound C.C[C@H](N)[13C](=O)O.C[C@H]([16NH2])C(=O)O.NCC(=O)O.O=C(O)CNC(=O)OCC1C2=C(C=CC=C2)C2=C1C=CC=C2.O=C(OCC1C2=C(C=CC=C2)C2=C1C=CC=C2)ON1C(=O)CCC1=O.[2H]C([2H])([2H])[C@@]([2H])(N)[13C](=O)O GMOOYOPDPCKCHO-LQRYGBJHSA-N 0.000 description 1
- WGSBTJUNYQKZDV-UHFFFAOYSA-N C1CCC1.C1CCC1.CC.CC Chemical compound C1CCC1.C1CCC1.CC.CC WGSBTJUNYQKZDV-UHFFFAOYSA-N 0.000 description 1
- WAWOXJLZEBJLSY-UHFFFAOYSA-N C=CC1=CC=CC=C1.C=CC1=CC=CC=C1.CCCC(CC(CCC)C1=CC=CC=C1)C1=CC=CC=C1.CF Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1.CCCC(CC(CCC)C1=CC=CC=C1)C1=CC=CC=C1.CF WAWOXJLZEBJLSY-UHFFFAOYSA-N 0.000 description 1
- BORGZSXKEPBCLU-UHFFFAOYSA-N CC(=O)NCCOCCOCCOCC1=CC=C(C)C=C1.CC(=O)NCCOCCOCCOCC1=CC=C(C)C=C1.CC(=O)NCCOCCOCCOCC1=CC=C(C)C=C1.CC(=O)NCCOCCOCCOCC1=CC=C(C)C=C1.CC(=O)NCCOCCOCCOCC1=CC=C(C)C=C1.CC(=O)NCCOCCOCCOCC1=CC=C(C)C=C1.CC(=O)NCCOCCOCCOCC1=CC=C(C)C=C1.CC(=O)NCCOCCOCCOCC1=CC=C(C)C=C1 Chemical compound CC(=O)NCCOCCOCCOCC1=CC=C(C)C=C1.CC(=O)NCCOCCOCCOCC1=CC=C(C)C=C1.CC(=O)NCCOCCOCCOCC1=CC=C(C)C=C1.CC(=O)NCCOCCOCCOCC1=CC=C(C)C=C1.CC(=O)NCCOCCOCCOCC1=CC=C(C)C=C1.CC(=O)NCCOCCOCCOCC1=CC=C(C)C=C1.CC(=O)NCCOCCOCCOCC1=CC=C(C)C=C1.CC(=O)NCCOCCOCCOCC1=CC=C(C)C=C1 BORGZSXKEPBCLU-UHFFFAOYSA-N 0.000 description 1
- FIBSCROGSCLZTE-UHFFFAOYSA-N CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC Chemical compound CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC FIBSCROGSCLZTE-UHFFFAOYSA-N 0.000 description 1
- DDBLCOVVLQJFFM-UHFFFAOYSA-N CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC Chemical compound CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC.CC DDBLCOVVLQJFFM-UHFFFAOYSA-N 0.000 description 1
- DWVHCTCJQMNOAA-RVPAVIEQSA-N CC1=CC=C(CN)C=C1.CC1=CC=C(CNC(=O)CC([15NH]C(=O)OCC2C3=C(C=CC=C3)C3=C2C=CC=C3)C2=C([N+](=O)[O-])C=CC=C2)C=C1.O=C(O)CC([15NH]C(=O)OCC1C2=CC=CC=C2C2=C1/C=C\C=C/2)C1=CC=CC=C1[N+](=O)[O-].[2H]CF.[2H][IH]C Chemical compound CC1=CC=C(CN)C=C1.CC1=CC=C(CNC(=O)CC([15NH]C(=O)OCC2C3=C(C=CC=C3)C3=C2C=CC=C3)C2=C([N+](=O)[O-])C=CC=C2)C=C1.O=C(O)CC([15NH]C(=O)OCC1C2=CC=CC=C2C2=C1/C=C\C=C/2)C1=CC=CC=C1[N+](=O)[O-].[2H]CF.[2H][IH]C DWVHCTCJQMNOAA-RVPAVIEQSA-N 0.000 description 1
- CFTADNKTEFGQKK-SGQHFKRESA-N CC1=CC=C(CN)C=C1.COC1=CC=C(C(C)C2=CC=C(OCC(=O)NCC3=CC=C(C)C=C3)C=C2)C(OC)=C1.COC1=CC=C(C([15NH]C(=O)OCC2C3=CC=CC=C3C3=C2/C=C\C=C/3)C2=CC=C(OCC(=O)O)C=C2)C(OC)=C1.O=COCC1C2=CC=CC=C2C2=C1/C=C\C=C/2.[2H]CF.[2H][IH]C Chemical compound CC1=CC=C(CN)C=C1.COC1=CC=C(C(C)C2=CC=C(OCC(=O)NCC3=CC=C(C)C=C3)C=C2)C(OC)=C1.COC1=CC=C(C([15NH]C(=O)OCC2C3=CC=CC=C3C3=C2/C=C\C=C/3)C2=CC=C(OCC(=O)O)C=C2)C(OC)=C1.O=COCC1C2=CC=CC=C2C2=C1/C=C\C=C/2.[2H]CF.[2H][IH]C CFTADNKTEFGQKK-SGQHFKRESA-N 0.000 description 1
- PEFRRDGWOOOFIO-GOZHDHSSSA-N CC1=CC=C(CNC(=O)CC([15NH]C(=O)C(C)C)C2=C([N+](=O)[O-])C=CC=C2)C=C1.CC1=CC=C(CNC(=O)CC([15NH]C(=O)OCC2C3=C(C=CC=C3)C3=C2C=CC=C3)C2=C([N+](=O)[O-])C=CC=C2)C=C1.CCN[C@H](C)C(=O)O Chemical compound CC1=CC=C(CNC(=O)CC([15NH]C(=O)C(C)C)C2=C([N+](=O)[O-])C=CC=C2)C=C1.CC1=CC=C(CNC(=O)CC([15NH]C(=O)OCC2C3=C(C=CC=C3)C3=C2C=CC=C3)C2=C([N+](=O)[O-])C=CC=C2)C=C1.CCN[C@H](C)C(=O)O PEFRRDGWOOOFIO-GOZHDHSSSA-N 0.000 description 1
- UZLMALZDXSSPHK-UHFFFAOYSA-N CC1=CC=C(COCCOCCOCCNC(=O)CC(CC(=O)OCC2C3=C(C=CC=C3)C3=C2C=CC=C3)C2=CC=CC=C2[N+](=O)[O-])C=C1 Chemical compound CC1=CC=C(COCCOCCOCCNC(=O)CC(CC(=O)OCC2C3=C(C=CC=C3)C3=C2C=CC=C3)C2=CC=CC=C2[N+](=O)[O-])C=C1 UZLMALZDXSSPHK-UHFFFAOYSA-N 0.000 description 1
- KKTJBZLFQXHOPZ-YQZXJOFRSA-N CC1=CC=C(COCCOCCOCCNC(=O)CNC(=O)OCC2C3=CC=CC=C3C3=C2C=CC=C3)C=C1.CCCO.COC1=CC(OC)=C(C(N[13C](=O)[13CH2]NC(=O)OCC2C3=CC=CC=C3C3=C2C=CC=C3)C2=CC=C(OCC(=O)NCCOCCOCCOCC3=CC=C(C)C=C3)C=C2)C=C1 Chemical compound CC1=CC=C(COCCOCCOCCNC(=O)CNC(=O)OCC2C3=CC=CC=C3C3=C2C=CC=C3)C=C1.CCCO.COC1=CC(OC)=C(C(N[13C](=O)[13CH2]NC(=O)OCC2C3=CC=CC=C3C3=C2C=CC=C3)C2=CC=C(OCC(=O)NCCOCCOCCOCC3=CC=C(C)C=C3)C=C2)C=C1 KKTJBZLFQXHOPZ-YQZXJOFRSA-N 0.000 description 1
- YFYJMULVTNGGGZ-UHFFFAOYSA-N CCC(C)C.CCOC.I.II Chemical compound CCC(C)C.CCOC.I.II YFYJMULVTNGGGZ-UHFFFAOYSA-N 0.000 description 1
- ZJUJJUVCCZVJIK-LPZRCUJESA-N CCN(CC)CC.O=C(O)CC([15NH]C(=O)OCC1C2=CC=CC=C2C2=C1/C=C\C=C/2)C1=CC=CC=C1[N+](=O)[O-].O=C(OCC1C2=C(C=CC=C2)C2=C/C=C/C=C\21)ON1C(=O)CCC1=O.O=CC1=CC=CC=C1[N+](=O)[O-].O=CC1=CC=CC=C1[N+](=O)[O-].[15NH2]C(CC(=O)O)C1=CC=CC=C1[N+](=O)[O-].[15NH2]C(CC(=O)O)C1=CC=CC=C1[N+](=O)[O-].[15NH2]C(CC(=O)O)C1=CC=CC=C1[N+](=O)[O-] Chemical compound CCN(CC)CC.O=C(O)CC([15NH]C(=O)OCC1C2=CC=CC=C2C2=C1/C=C\C=C/2)C1=CC=CC=C1[N+](=O)[O-].O=C(OCC1C2=C(C=CC=C2)C2=C/C=C/C=C\21)ON1C(=O)CCC1=O.O=CC1=CC=CC=C1[N+](=O)[O-].O=CC1=CC=CC=C1[N+](=O)[O-].[15NH2]C(CC(=O)O)C1=CC=CC=C1[N+](=O)[O-].[15NH2]C(CC(=O)O)C1=CC=CC=C1[N+](=O)[O-].[15NH2]C(CC(=O)O)C1=CC=CC=C1[N+](=O)[O-] ZJUJJUVCCZVJIK-LPZRCUJESA-N 0.000 description 1
- PTKJNTLOUDNRML-BSPXWSGBSA-N CCN(CC)CC.O=C(O)CC([15NH]C(=O)OCC1C2=CC=CC=C2C2=C1/C=C\C=C/2)C1=CC=CC=C1[N+](=O)[O-].O=C(OCC1C2=C(C=CC=C2)C2=C/C=C/C=C\21)ON1C(=O)CCC1=O.[15NH2]C(CC(=O)O)C1=CC=CC=C1[N+](=O)[O-] Chemical compound CCN(CC)CC.O=C(O)CC([15NH]C(=O)OCC1C2=CC=CC=C2C2=C1/C=C\C=C/2)C1=CC=CC=C1[N+](=O)[O-].O=C(OCC1C2=C(C=CC=C2)C2=C/C=C/C=C\21)ON1C(=O)CCC1=O.[15NH2]C(CC(=O)O)C1=CC=CC=C1[N+](=O)[O-] PTKJNTLOUDNRML-BSPXWSGBSA-N 0.000 description 1
- POZJJFYVRZXIFK-UHFFFAOYSA-N COC1=CC=C(C(=O)C2=CC=C(CCC(=O)O)C=C2)C(OC)=C1.COC1=CC=C(C(O)C2=CC=C(O)C=C2)C(OC)=C1 Chemical compound COC1=CC=C(C(=O)C2=CC=C(CCC(=O)O)C=C2)C(OC)=C1.COC1=CC=C(C(O)C2=CC=C(O)C=C2)C(OC)=C1 POZJJFYVRZXIFK-UHFFFAOYSA-N 0.000 description 1
- CAMDKRLOJNIGBD-AEGFGLIESA-M COC1=CC=C(C(=O)C2=CC=C(O)C=C2)C(OC)=C1.COC1=CC=C(C(=O)C2=CC=C(OCC(=O)O)C=C2)C(OC)=C1.COC1=CC=C(C(O)C2=CC=C(OCC(=O)O)C=C2)C(OC)=C1.COC1=CC=C(C([15NH]C(=O)OCC2C3=CC=CC=C3C3=C2C=CC=C3)C2=CC=C(OCC(=O)O)C=C2)C(OC)=C1.COC1=CC=CC(OC)=C1.O=C(CCl)O[Na].O=C(O)C1=CC=C(O)C=C1.O=P(Cl)(Cl)Cl.[15NH2]C(=O)OCC1C2=C(C=CC=C2)C2=C1/C=C\C=C/2 Chemical compound COC1=CC=C(C(=O)C2=CC=C(O)C=C2)C(OC)=C1.COC1=CC=C(C(=O)C2=CC=C(OCC(=O)O)C=C2)C(OC)=C1.COC1=CC=C(C(O)C2=CC=C(OCC(=O)O)C=C2)C(OC)=C1.COC1=CC=C(C([15NH]C(=O)OCC2C3=CC=CC=C3C3=C2C=CC=C3)C2=CC=C(OCC(=O)O)C=C2)C(OC)=C1.COC1=CC=CC(OC)=C1.O=C(CCl)O[Na].O=C(O)C1=CC=C(O)C=C1.O=P(Cl)(Cl)Cl.[15NH2]C(=O)OCC1C2=C(C=CC=C2)C2=C1/C=C\C=C/2 CAMDKRLOJNIGBD-AEGFGLIESA-M 0.000 description 1
- HKHZHXJNQQCIEB-UHFFFAOYSA-M COC1=CC=C(C(=O)C2=CC=C(O)C=C2)C(OC)=C1.COC1=CC=C(C(=O)C2=CC=C(OCC(=O)O)C=C2)C(OC)=C1.O=C(CCl)O[Na] Chemical compound COC1=CC=C(C(=O)C2=CC=C(O)C=C2)C(OC)=C1.COC1=CC=C(C(=O)C2=CC=C(OCC(=O)O)C=C2)C(OC)=C1.O=C(CCl)O[Na] HKHZHXJNQQCIEB-UHFFFAOYSA-M 0.000 description 1
- XZHCPUDDDXWHMA-UHFFFAOYSA-N COC1=CC=C(C(=O)C2=CC=C(O)C=C2)C(OC)=C1.COC1=CC=CC(OC)=C1.O=C(O)C1=CC=C(O)C=C1.O=P(Cl)(Cl)Cl Chemical compound COC1=CC=C(C(=O)C2=CC=C(O)C=C2)C(OC)=C1.COC1=CC=CC(OC)=C1.O=C(O)C1=CC=C(O)C=C1.O=P(Cl)(Cl)Cl XZHCPUDDDXWHMA-UHFFFAOYSA-N 0.000 description 1
- LQOTVINCWHJAKA-WUYSRGLGSA-N COC1=CC=C(C(O)C2=CC=C(OCC(=O)O)C=C2)C(OC)=C1.COC1=CC=C(C([15NH]C(=O)OCC2C3=CC=CC=C3C3=C2C=CC=C3)C2=CC=C(OCC(=O)O)C=C2)C(OC)=C1.[15NH2]C(=O)OCC1C2=C(C=CC=C2)C2=C1/C=C\C=C/2 Chemical compound COC1=CC=C(C(O)C2=CC=C(OCC(=O)O)C=C2)C(OC)=C1.COC1=CC=C(C([15NH]C(=O)OCC2C3=CC=CC=C3C3=C2C=CC=C3)C2=CC=C(OCC(=O)O)C=C2)C(OC)=C1.[15NH2]C(=O)OCC1C2=C(C=CC=C2)C2=C1/C=C\C=C/2 LQOTVINCWHJAKA-WUYSRGLGSA-N 0.000 description 1
- YMSZFQVDZUKSFV-UHFFFAOYSA-N COc1cc(OC)c(C(c(cc2)ccc2OCC(O)=O)N)cc1 Chemical compound COc1cc(OC)c(C(c(cc2)ccc2OCC(O)=O)N)cc1 YMSZFQVDZUKSFV-UHFFFAOYSA-N 0.000 description 1
- MUTGETALXYGSCX-UHFFFAOYSA-N COc1cc(OC)c(C(c(cc2)ccc2OCC(O)=O)O)cc1 Chemical compound COc1cc(OC)c(C(c(cc2)ccc2OCC(O)=O)O)cc1 MUTGETALXYGSCX-UHFFFAOYSA-N 0.000 description 1
- JZNGILSSCUIFMF-PEUYWAPVSA-N NC[13C](=O)O.N[13CH2][13C](=O)O.[16NH2]CC(=O)O.[2H]C([2H])(N)C(=O)O Chemical compound NC[13C](=O)O.N[13CH2][13C](=O)O.[16NH2]CC(=O)O.[2H]C([2H])(N)C(=O)O JZNGILSSCUIFMF-PEUYWAPVSA-N 0.000 description 1
- CQLMKFDBRAMCFF-HRZZEPNDSA-N O=C(Cl)OCC1C2=CC=CC=C2C2=C1/C=C\C=C/2.[15NH2]C(=O)OCC1C2=CC=CC=C2C2=C1/C=C\C=C/2 Chemical compound O=C(Cl)OCC1C2=CC=CC=C2C2=C1/C=C\C=C/2.[15NH2]C(=O)OCC1C2=CC=CC=C2C2=C1/C=C\C=C/2 CQLMKFDBRAMCFF-HRZZEPNDSA-N 0.000 description 1
- HEBCPALCYYFINC-JMZUUDKXSA-N O=C(O)[13CH2]Br.O=[13C](O)[13CH2]Br.O=[13C](O)[13CH2]Br Chemical compound O=C(O)[13CH2]Br.O=[13C](O)[13CH2]Br.O=[13C](O)[13CH2]Br HEBCPALCYYFINC-JMZUUDKXSA-N 0.000 description 1
- UHTHWLWNIFGAFO-VZRNLXGGSA-N [H]N(C)C(=O)C[C@]([H])(C1=C([N+](=O)[O-])C=CC=C1)N([H])C(=O)CN([H])C(=O)[C@@H](C)N([H])C(=O)COC1=CC=C([C@@]([H])(C2=CC=C(OC)C=C2OC)N([H])C)C=C1.[H]N(C)C(=O)C[C@]([H])(C1=C([N+](=O)[O-])C=CC=C1)N([H])C(=O)CN([H])C(=O)[C@@H](C)N([H])C(=O)COC1=CC=C([C@]([H])(C2=CC=C(OC)C=C2OC)N([H])C)C=C1.[H]N(C)C(=O)C[C@]([H])(C1=C([N+](=O)[O-])C=CC=C1)N([H])C(=O)CN([H])C(=O)[C@H](C)N([H])C(=O)COC1=CC=C([C@@]([H])(C2=CC=C(OC)C=C2OC)N([H])C)C=C1.[H]N(C)C(=O)C[C@]([H])(C1=C([N+](=O)[O-])C=CC=C1)N([H])C(=O)CN([H])C(=O)[C@H](C)N([H])C(=O)COC1=CC=C([C@]([H])(C2=CC=C(OC)C=C2OC)N([H])C)C=C1 Chemical compound [H]N(C)C(=O)C[C@]([H])(C1=C([N+](=O)[O-])C=CC=C1)N([H])C(=O)CN([H])C(=O)[C@@H](C)N([H])C(=O)COC1=CC=C([C@@]([H])(C2=CC=C(OC)C=C2OC)N([H])C)C=C1.[H]N(C)C(=O)C[C@]([H])(C1=C([N+](=O)[O-])C=CC=C1)N([H])C(=O)CN([H])C(=O)[C@@H](C)N([H])C(=O)COC1=CC=C([C@]([H])(C2=CC=C(OC)C=C2OC)N([H])C)C=C1.[H]N(C)C(=O)C[C@]([H])(C1=C([N+](=O)[O-])C=CC=C1)N([H])C(=O)CN([H])C(=O)[C@H](C)N([H])C(=O)COC1=CC=C([C@@]([H])(C2=CC=C(OC)C=C2OC)N([H])C)C=C1.[H]N(C)C(=O)C[C@]([H])(C1=C([N+](=O)[O-])C=CC=C1)N([H])C(=O)CN([H])C(=O)[C@H](C)N([H])C(=O)COC1=CC=C([C@]([H])(C2=CC=C(OC)C=C2OC)N([H])C)C=C1 UHTHWLWNIFGAFO-VZRNLXGGSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Definitions
- the present invention generally relates to the field of combinatorial chemistry and in particular relates to encoding the library products of combinatorial synthesis.
- Chemical libraries are intentionally created collections of differing molecules which can be prepared either synthetically or biosynthetically and screened for biological activity in a variety of different formats.
- Chemical libraries are advantageously made by using techniques from the field of combinatorial chemistry.
- the field of combinatorial chemistry is a synthetic strategy which leads to large chemical libraries.
- Combinatorial chemistry can be defined as the systematic and repetitive covalent connection of a set of different building blocks of varying structures to each other to yield a large array of diverse molecular entitites.
- a typical combinatorial synthesis technique is that of the split synthesis.
- split synthesis in the solid state synthesis of peptides, a batch of resin support (typically small resin beads) is divided into n fractions, coupling a single monomer amino acid to each aliquot in a separate reaction, and then throroughly mixing all the resin particles together.
- each tag would then convey which building block was coupled in a particular step of the synthesis, and the overall structure of a ligand on any bead could be deduced by “reading” the set of tags on that bead, in effect having encoded the bead.
- Tags should ideally have a highly discrete information content, be amenable to very high sensitivity detection and decoding, and must be stable to reagents used in the ligand synthesis.
- Prior art tags attached onto beads have included nucleotides, peptides, or a combined series of hydrocarbon homologs and polychlorinated aromatics.
- Single stranded oligonucleotides are built on resin beads upon which peptide synthesis is being performed and which are subsequently amplified through polymerase chain reaction and sequenced.
- Another technique is one where orthogonally differentiated diamine linkers are used in the construction of soluble chimeric peptides comprising a “binding” strand and a “coding” strand.
- reagents may be organic or inorganic reagents, where functionalities may be introduced or modified, side groups attached or removed, rings opened or closed, stereochemistry changed, and the like.
- a technique that is useful for the screening of nonsequenceable organic molecules prepared by multistep combinatorial synthesis uses a series of gas chromatographically resolvable halocarbon derivatives as molecular tags which, when appended to reactive groups on the bead surface, can constitute a binary code that reflects the chemical history of any member of a library.
- the binary strategy uses a uniquely defined mixture of tags to represent each building block at each particular step of the synthesis.
- a set of N tags can be used to encode the combinatorial synthesis of a library of 2 N different members. After assembly, the tags are photolysed and analyzed by electron capture capillary gas chromatography.
- Yet another method is that of using a chip which allows for separate analysis at physically separate sites on the surface of the chip. By knowing what reactant is added sequentially at each such site, one can record the sequence of events and thus the series of reactions. If one then subjects the chip to a screening method for a particular desired characteristic and detects the characteristic one can readily determine the compound synthesized at the site which demonstrates that characteristic.
- the present invention embodies a method of isotopically rather than chemically encoding a monomer to read a synthetic history. Readable differences in the encoding moieties therefore rely on physical differentiation, rather than chemical differentiation.
- the isotopically encoded monomer is, however, chemically bonded to the ligand of interest during-synthesis, in contrast to prior art identification methods in which differentiable isotopes are physically mixed into and interspersed with bulk chemicals or commodities to identify their, manufacturing source.
- the invention likewise does not rely on tagging a molecule, like other prior art approaches.
- FIG. 1 is an array of MS peaks that represent the observed peak signatures for the doped glycine code blocks described in the specification below.
- FIG. 2 is a graph that shows the observed correlation between number of carbon atoms present and the fraction of link content that has N 15 present. The chart can be used to calculate equal intensity peak signatures.
- FIG. 3 illustrates a two peak positional coding strategy for a molecule, featuring splitting MS peaks into doublets to enhance code recognition.
- FIG. 4 illustrates the observed correlation between MS peak area and ratio of N 15 present in a code sample for a series of code samples differing in N 15 content by 5% increments.
- FIG. 5 is an NMR peak pattern for the compound:
- FIG. 6 is an NMR peak pattern for the compound:
- FIG. 7 is an NMR peak pattern for the compound:
- FIG. 8 is an NMR peak pattern for the compound:
- FIG. 9 is a chart that correlates the observed ratio of C 13 to C 12 in the NMR spectra of FIGS. 5 through 8 with the % of C 13 present in each.
- FIGS. 10 through 12 show spectra observed in conjunction with the Example 23 procedure on the Reaction Screening embodiment of the invention.
- FIGS. 13 through 17 show synthesis flow diagrams used in the Example 23 disclosure on the Reaction Screening embodiment of the invention.
- FIGS. 18 through 51 show, spectra observed in conjunction with the Example 24 disclosure of the Ratio Coding embodiment of the invention.
- FIGS. 52 through 110 show spectra that are produced in conjunction the disclosure of Example 25 of encoding styrene and Example 26 disclosing copolymerization of styrene and F-styrene.
- FIGS. 111 through 132 show spectra representing the decoding of a parallel synthesis of a library on encoded resin beads, using a dual linker approach in which a first linker was a photocleavable linker and a second linker was a Knorr linker.
- FIGS. 133 to 286 are spectra that are produced by a set of code blocks organized in a type of ratio encoding designated as four peak ratio encoding, using four isotopically distinct F-moc protected versions of alanine
- FIG. 287 is a flow diagram for a computer program capable of automating the decoding of a set of code blocks and their associated spectra.
- the invention is the application of mass or isotopic encoding in the imprinting of coded information into or in conjunction with materials or processes shch that the details of the components or process steps can be easily determined by one or more of the methods of mass spectrometry, nuclear magnetic resonance spectroscopy, or infrared spectroscopy, including the technique of Ramen spectroscopy.
- the invention is a method of encoding the products of combinatorial synthesis by isotopically doping a portion of a combinatorial chemistry construct and analyzing the combinatorial reaction products by mass spectrometry, nuclear magnetic resonance spectroscopy or infrared spectroscopy.
- the invention comprises several embodiments.
- the invention comprises a mass-based, non-chemical method for recording the reaction of at least a portion of a reaction series on each of a plurality of unique solid supports, the method comprising: preparing a plurality of agents each having a unique defined mass; preparing a group of unique solid supports; reacting each solid support group with a different chemical reagent under a controlled reaction condition; mixing these product groups together and then dividing the mixture of unique solid supports into a plurality of groups for a second intermediate or final stage; repeating the reacting stage with a chemical reagent under a controlled reaction condition at least once to provide a plurality of final products, having different products on the different individual unique solid supports; each of the unique defined mass agents being reacted with either: each of a group of unique solid supports; each of a group of first chemical reagents in a reaction series; each of a group of second chemical reagents in a reaction series; or each of a group of subsequently added chemical
- the method is particularly preferred in performing an assay or using separation techniques including column or plate chromatography or fluorescence assistance cell scanning to find reaction products having a characteristic of interest and then performing the identification analysis on such reaction products.
- This method is particularly preferred with respect to the determination of the first chemical reagent added to the reaction sequence.
- Reaction products can include a non-oligomer which is aliphatic, alicyclic, aromatic, or heterocyclic or an oligomer which is an oligopeptide, oligonucleotide, oligosaccharide, polylipid, polyester, polyamide, polyurethane, polyurea, polyether, polyphosphorus derivative where the phosporus is taken from the group consisting of phosphate, phosphonate, phosphoramide, phosphonamide, phosphite, or phosfinamide, or polysulfur derivative where the sulfur is taken from the group consisting of sulfone, sulfonate, sulfite, sulfinamide, or sulfenamide.
- Preferred means of analysis are by mass spectrometry (MS), nuclear magnetic resonance (NMR) spectroscopy, and infrared or Raman spectroscopy. These means of analysis produce distinctive peak patterns used in analysis, identification, coding and decoding strategies.
- the mass spectrometer in particular produces unique single mass peaks, unique double mass peaks, unique pairs of single mass peaks, unique pairs of double mass peaks and other unique multiple peak patterns, which are additionally capable of being translated into machine-readable patterns, including bar codes.
- the NMR, IR and Raman methods also produce useful unique peak patterns that can be transformed into machine-readable patterns, including bar codes.
- Such patterns can be assigned in encoding strategies to represent discrete chemical reagents added in a chemical reaction series, or assigned to represent discrete chemical reaction conditions under which a chemical reagent was added in a reaction series, including, but not limited to, concentrations, temperatures, pressures, catalysts, enzymes, electromagnetic energy imparted to the system (visible light conditions, irradiation, etc.), and so on.
- This is done by initially generating recognition patterns for unique mass defined agents which are either eye-readable or machine-readable.
- the patterns resulting from the analysis steps are then compared to the recognition patterns for identification and decoding, with or without the assistance of a machine.
- Recognition patterns and analysis patterns that are machine-readable are capable of being stored electronically in suitable computer storage and memory devices well known to those of ordinary skill in the art and such stored patterns form a readily retrievable database that also forms a claimed embodiment of the invention.
- Mass agents used in these methods are preferably a molecular entity such as a solid state chemistry support resin bead linker which has had one or more of its atoms replaced by an isotope of that atom, thus altering the mass, but not the chemical properties of that chemical entity.
- a molecular entity such as a solid state chemistry support resin bead linker which has had one or more of its atoms replaced by an isotope of that atom, thus altering the mass, but not the chemical properties of that chemical entity.
- Another alternative mass agent is to simply repeat the appearance of such a molecular entity an integral number of times in a linear chemical construct.
- the method of the invention can be performed using solid state chemistry or solution chemistry.
- Reaction products can be cleaved off of a solid support for analysis, or the entire construct can be analyzed.
- Chemical reagents added to a reaction series can include one or more that can act as a substrate for the determination of binding specificity to a chemical compound of interest. Any or all of the steps of encoding, synthesis, analysis and decoding can be automated with the aid of suitable computer means and robotics means, all by methodologies well known to those of ordinary skill in the combinatorial chemistry, spectroscopy, computer science, robotics and optical scanning arts.
- kits made up of a set of compounds prepared for the encoding, synthesis, analysis and decoding methods described above of chemical reagents and reaction conditions in chemical reactions of interest in a combinatorial synthesis, where the compounds in the kit have different distinguishable masses, but the same chemical properties.
- kits can comprise solid state supports attached to isotopically doped linkers, series or combinations of isotope mixtures in readily identifiable ratios, or a variety of combinations of isotopically doped chemical moieties (also called code blocks herein) with covalent bonds or or other organic moieties as links or linkers.
- the invention also comprises kits of solid state supports that have been prepared so as to bear unique defined mass agents on their surface.
- Solid supports can be resin beads in a wide range of sizes of from 1 to 10,000 ⁇ m in dimension.
- the support itself can be isotopically doped by incorporating an isotope into the chemical structure of the support. This differentiates the mass of the support from like supports, but does not change its chemical properties.
- Such solid supports would then be used in the methods of the invention.
- Groups of such uniquely mass-defined supports can comprise libraries, which are also an embodiment of the invention as claimed herein.
- isotopic doping or “isotopically doped” is used here to mean the introduction, into a molecule of an isotope of one or more of the atoms normally appearing in that molecule.
- a “link” is a covalent bond or a molecular moiety that is suitable for linking two portions of a construct together.
- a “linker” is a moiety comprised of a code block, a first link for bonding the code block to a solid support or other moiety, and a second link for bonding the code block to a ligand or other moiety.
- a “linker mix” is a mixture of two isotopically distinct but chemically identical molecules, the mix having a discrete ratio of first isotope to second isotope.
- a “code block” is a molecule or series of molecules containing one or more isotopically doped atoms or having a repeating number of molecules in series, such that its mass can be discretely defined and differentiated from any other code block.
- a “doped” atom, code block or moiety refers to an entity in which an atom in a molecule which has been replaced by one of its isotopes.
- Doped atoms as contemplated by this invention include all atoms found in organic chemistry having isotopes and in particular, hydrogen, carbon, nitrogen, fluorine and oxygen. Non-radioactive isotopes are generally preferred over radioactive ones.
- the term “monomer” is used herein not only to denote subunits that make up a linear molecules such as amino acids, but also to denote starting chemical materials and chemical reagents that are chemically reacted with one another in combinatorial chemistry organic synthesis to produce molecules that are not linear, such products including so-called “small molecules” which are organic molecules of 500 Daltons or less in molecular weight.
- the terms “monomer” and “chemical reagent” are interchangeable.
- reaction series refers to a series of steps in a chemical synthesis in a combinatorial synthesis format.
- a “solid support” is one or materials upon which combinatorial chemistry syntheses can be performed, including beads, solid surfaces. solid substrates, particles, pellets, disks, capillaries, hollow fibers, needles, solid fibers, cellulose beads, pore-glass beads, silica gels, polystyrene beads optionally crosslinked with divinylbenzene, grafted co-polybeads, poly-acrylamide beads, latex beads, dimethylacrylamide beads optionally cross-linked with N,N′-bis-acryloyl ethylene diamine, glass particles coated with a hydrophobic polymer, fullerenes and soluble supports such as low molecular weight non-cross-linked polystyrene.
- a “construct” is a covalently bonded entity comprising, in any combination, some type of solid support, one or more linkers, one or more code blocks, and one or more ligands.
- a “ligand” is a chemical reaction product of interest.
- a ligand can be part of a larger construct, where the ultimate goal will be to identify and/or cleave the ligand apart from the rest of the construct.
- Isotopes are inserted into such constructs via doped links. That is, after the determination has been made as to what will constitute a chemically suitable link, the link is synthesized using one or more atoms of the link that has been substituted by an isotopic form of that atom. The isotopic form is chemically indistinguishable from the non-isotopic form of the link. The isotopic form is, however physically distinguishable from other isotopic forms by MS or NMR analysis. This physical difference is manifested by differently appearing MS, IR, or NM R peak patterns. A wide variety of isotopic insertion or doping strategies are available, leading to a large number of physically distinguishable chemical moieties, each having its own distinctive peak pattern.
- Electrospray mass spectrometry provides mass and ionic charge intensity information for a given molecular entity.
- smaller molecules only appear in the spectrum once as singly charged species, and the effect of isotopic compositional variation results in a very predictable quantum mass shift.
- a molecule having a molecular weight of 304 will produce a peak at 305 (M+1) on a mass spectrometer (MS) spectrum. If a nitrogen atom in such molecule having an atomic weight of 14 (N 14 ) is replaced (by isotopic doping, as that term is used herein) by isotope N 15 , then the MS peak will shift to the right precisely one unit to 306.
- a series of isotopically doped linker mixes n is prepared, with each linker mix in the series comprising a discrete ratio of first isotope to second isotope, and with each mix in the series differing in ratio from the previous or subsequent mix in the series by an equal amount.
- a series of 21 batches of doped monomer can be prepared, with the first batch in the series having a-ratio of 100% of first isotope to 0% of second isotope, the second batch having a ratio of 95% of first isotope to 5% of second isotope, and so on until the 21st batch, which will have 0% of first isotope and 100% of second isotope.
- Each linker is further characterized by being capable of being cleaved such that one cleavage portion will always contain the isotopically doped molecular moiety.
- Each linker mix is chemically reacted with a support means on one side of the linker to yield n batches of support-linker, again each having a discrete ratio of first to second isotope. Then a reagent of interest is added to each batch to yield n batches of support-linker-molecule, each likewise having the discrete ratios of two isotopes.
- n batches are combined into a single mixing vessel and the resulting mix is then divided into n aliquots, and to each aliquot is added a second reagent of interest, and the resultant reactions are allowed to proceed.
- the previous step of combining all aliquots and then splitting them out into n aliquots is repeated, and a third reagent of interest can be added. If all possible reactions have proceeded to completion, then there are now n 3 products.
- the linkers can be cleaved so that the isotopically labeled fragment stays with the chemical product, and the resulting isotope label-chemical product construct is analyzed by a mass spectrometer.
- the resulting mass spectrogram will display a peak pattern that mirrors the ratio of first isotope to second isotope present in the linker fragment, thus identifying what the first chemical reagent was that was added to that particular reaction well.
- the isotope ratio is 100% for first isotope to 0% for second isotope
- one relatively tall peak will appear on the spectrogram at the position on the spectrum occupied by -the discrete atomic mass that that moiety has (as will be appreciated by those of ordinary skill in the art, other relatively small peaks, will, of course appear, but just one prominent peak that is characteristic of the molecule as used in the identification method of the present invention appears.).
- the isotope ratio is 95% of first isotope to 5% of second isotope, then there will be a first prominent peak and a second prominent peak, with the first prominent peak having about 95% of the total area under the combined prominent peaks, and the second prominent peak having the remaining approximately 5%, thus forming a distinct prominent peak pattern which serves to clearly identify the isotope ratio and therefore the chemical reagent. It is to be understood that another smaller peak not part of the patterns forming the codes of the invention will-appear, by virtue of the natural abundance of C 13 , and its relative size can be predicted using the following analysis.
- the isotopically distinct species used should differ by two or more AMUs as this would produce well separated peaks that would not be affected by the natural presence of 13 C.
- C,H,N,O the atoms that are most commonly used in such chemistry typically requires that more than one atom be isotopically substituted, as available stable isotopes of C, H and N differ by only one mass unit.
- the third component can be identified by its reaction well number. Now, with the identity of the first component known by virtue of the mass spectrograph and the third component known by virtue of the well number, their combined molecular weights are subtracted from the total molecular weight of the construct to arrive at a residual mass which identifies the second component of the construct.
- the mass spectrograph peak pattern for the doped nitrogen identifies the first synthesis component
- the mass spectrograph peak pattern for the doped carbon identifies the second synthesis component
- an assay identifies the fourth component
- the third component is identified by subtraction of the first, second and fourth components from the total weight of the product.
- code degeneration may arise when using more than one type of isotope, as in the case where one moiety bore a N 15 -C 12 combination and another bore a N 14 -C 13 combination, both of which would have the same atomic weight and therefore give indistinguishable peak patterns in a mass spectrograph.
- This problem can be circumvented in one of two general ways. Firstly, by selecting C 12 and C 14 as the carbon isotope pair, this type of code degeneracy is avoided. Or, if radioactivity is to be avoided, C 12 and C 13 can still, be used by the technique of combining mass spectrography with fragmentation. For example, an amide moiety of the structure
- [0062] can be doped in two ways that will yield the same atomic weight as follows:
- moiety I when they are fragmented along the indicated cleavage lines, moiety I will yield a fragment having a doped N and a normal C, while moiety II will yield a fragment having, a doped C and a normal N, thereby yielding distinctive peak patterns in the MS.
- the first and second links in a linker scheme can be the same or different.
- the links can be the same when a direct binding assay is used, followed by removal of positive beads. When the links are different, this allows the assay to be either by direct binding or with cleaved ligand alone.
- Decoding of a three monomer combinatorial- library is achieved from three steps.
- the mass of the code block is determined, thus identifying the code, which identifies the first pool monomer.
- the pool number of the final monomer addition determines the final monomer, from which the mass of the final monomer is known.
- the masses of the first and third pool monomers are subtracted from the total molecular weight of the entire construct, thus leaving the mass of the second pool monomer, from which the identity of the second pool monomer is inferred.
- Another alternative embodiment of the invention of isotopic encoding can follow a double MS peak position strategy.
- This approach yields two MS peaks.
- a set of resin beads is prepared wherein the beads bear two protected sites, such as BOC and FMOC.
- a first protected site is de-protected.
- a number of isotopic code blocks n is prepared and each code is linked to a first de-protected site.
- the second, protected site is de-protected.
- a standard reference moiety having a different mass is linked to the second de-protected site.
- MS Upon MS, this will yield a peak for the standard reference and a second peak for the code, with the mass difference between the two peaks being the encoding unit.
- Decoding of a three monomer combinatorial library is achieved from three steps. The mass of the ligand plus code block is determined, thus identifying the code, which identifies the first pool monomer. The pool number of the final monomer addition determines the final monomer, from which the mass of the final monomer is known. Then, the masses of the first and third pool monomers are subtracted from the total molecular weight of the entire construct, thus leaving the mass of the second pool monomer, from which the identity of the second pool monomer is inferred.
- the code block is prepared to contain two like species, one of which is constant and acts as a reference mass, while the other has variable mass blocks similar to those described for the single peak positional encoding scheme.
- ligand is generated with an attached variable code increment.
- the encoded information is now determined from the difference in mass of the coding unit and the reference mass unit.
- MS This strategy gives two mass peaks that represent the ligand attached to either the reference code or the variable code.
- the difference in mass is used to determine the identity of monomer 1, while monomer 3 known from the corresponding pool and therefore monomer 2 is inferred as described above.
- the invention also makes possible an alternative embodiment that in effect creates a bar coding mechanism.
- Several non-limiting exemplary versions of solid state constructs are possible as follows.
- a code block most advantageously consists of a dimer, each of which unit has one, two or three discrete masses.
- a construct of the structure contains a code block having two mass blocks, M 1 and M 2 , which in this example will be comprised of one, two or three amino acids.
- the amino acids are doped to give three discrete masses yielding, for example, Glycine (G 0 ), with a mass of 57, Glycine bearing N 15 (G 1 ) with a mass of 58 and Glycine bearing two Deuterium atoms (G 2 ) at carbon 2 with a mass of 59.
- the pattern is compared to a predicted pattern, which in turn identifies the code, which in turn identifies the first pool monomer.
- the predicted patterns can form a type of machine readable bar code, which, using methods well known to those of ordinary skill in the optical scanning art, enables rapid data inputing, decoding and interpretation.
- isotope doping occurs at the bead link and attached to the end of a three monomer ligand, as indicated by the asterisk. Isotope doping could also be performed at the other end of the ligand as well.
- NMR nuclear magnetic resonance
- FIGS. 133 to 286 display spectragrams associated with another variation of ratio encoding, which is a four peak ratio encoding scheme.
- the first column represents the code block
- the second column is an internal reference number
- the third, fourth, fifth and sixth columns represent the respective mole fractions of FMOC-protected alanines with different integral masses using isotope doping, i.e. A 0 , A 3 , A 2 , and A 1 (A is reference alanine, A 3 is alanine plus 3 atomic mass units, A 2 is alanine plus two atomic mass units, etc.).
- the R 1 moiety is encoded by the C 12 to C 13 ratio sample
- the R 3 is encoded by the pool number from R 3 was taken
- the R 2 moiety is encoded by subtraction of the known R 1 and R 3 masses from the total construct mass.
- Fmoc-protected alanine, serine and lysine were purchased from Bachem Bioscience.
- Fmoc-glycine was purchased from Novabiochem.
- Isotopically labeled amino acids were purchased from Cambridge Isotope Laboratories and were Fmoc protected in house (GP).
- Fmoc Knorr linker was purchased from Novabiochem.
- Fmoc-3-(2-nitrophenyl)-3-aminopropionic acid (a photolabile linkage agent) was purchased from Universal Organics.
- Aminomethyl polystyrene resin (0.81 mmol/gram) was purchased from Advanced ChemTech.
- Linkers were attached to solid support manually in reaction shakers (CM). Resin was split, to 85 reaction vessels on an Advanced ChemTech ACT496 MBS. Resin was deprotected with 25% piperidine/dimethylformamide twice for 10 minutes, then washed thoroughly with dimethylformamide. The first amino acids were coupled as 0.142 M solutions in N-methyl-pyrolidone, with PyBOP/Diisopropylethylamine in situ activation for 1.5 hours at room temperature. Boc deprotection was performed with 25 % trifluoroacetic acid in dichloromethane for 30 minutes. Acetylations were performed with 33 % acetic anhydride in dimethyl formamide for 30 minutes.
- This array was designed to produce 20 samples with singlet, unique molecular weights for positive identification by mass spectroscopy.
- the samples were assembled in duplicate, one set of twenty on a chemically cleavable solid support, and the second set of twenty on a photocleavable support.
- a “coding region” was generated before addition of the synthetic ligand (in this case
- Acetyl-lysine The twenty codes were constructed from the following amino acids:
- lysine was coupled as a test ligand as well as to generate a free amino side chain for ease of observation by mass spectroscopy.
- the a-amino group of the lysine was then acetylated.
- FIG. 1 Position Position Position Total 1 2 3 MW 1 Ac- X X 187 Lys- 2 Ac- X -Gly0- 244 Lys- 3 Ac- X -Gly1- 245 Lys- 4 Ac- X -Gly2- 246 Lys- 5 Ac- X -Ala0- 258 Lys- 6 Ac- X -Ala1- 259 Lys- 7 Ac- X -Ala4- 262 Lys 8 Ac- X -Ser- 274 Lys- 9 Ac- -Gly0- -Gly0- 301 Lys- 1 Ac- -Gly0- -Gly1- 302 0 Lys- 1 Ac- -Gly1- -Gly1- 303 1 Lys- 1 Ac- -Gly2- -Gly1- 304 2 Lys- 1 Ac- -Gly2- -Gly2- 305 3 Lys- 1 Ac- - - -
- This array was designed to produce 20 samples with doublet peaks by mass spectroscopy; one peak arising from the ligand attached to a unique code, with a second peak resulting from a simultaneously assembled reference peak (ligand plus a fixed residue).
- a “coding region” was generated before addition of the synthetic ligand (in this case Acetyl-lysine).
- the twenty codes were also constructed from the following amino acids:
- FIG. 2 Position Position Position 1 2 3 Mwt 1 Ac- X X 187 Lys- 2 Ac- X -Gly0- 244 Lys- 3 Ac- X -Gly1- 245 Lys- 4 Ac- X -Gly2- 246 Lys- 5 Ac- X -Ala0- 258 Lys- 6 Ac- X -Ala1- 259 Lys- 7 Ac- X -Ala4- 262 Lys- 8 Ac- X -Ser- 274 Lys- 9 Ac- -Gly0- -Gly0- 301 Lys- 1 Ac- -Gly0- -Gly1- 302 0 Lys- 1 Ac- -Gly1- -Gly1- 303 1 Lys 1 Ac- -Gly2- -Gly1- 304 2 Lys- 1 Ac- -Gly2- -Gly2- 305 3 Lys- 1 Ac- -Ala0-
- This array will produce twenty five samples, each dislying a unique molecular ion or peak pattern by mass spectroscopy. By using only combinations of isotopically labeled glycine at only two positions, twenty five unique “barcodes” are produced. In this manner the first pooled lot of any single bead derived from a split-combine library can be readily identified.
- FIG. 3 Peak Position 1 Position 2 Position 3 Pattern 1 Ac- -G0- -G0- 1 Lys- 2 Ac- -G1- -G0- 1 Lys- 3 Ac- -G0/G1- -G0- 1:1 Lys- 4 Ac- -G2- -G0- 1 Lys- 5 Ac- -G0/G2- -G0- 1:1 Lys- 6 Ac- -G1/G2- -G0- 1:1 Lys- 7 Ac- — -G0- 1:1:1 Lys- G0/G1/G2- 8 Ac- -G2- -G1- 1 Lys- 9 Ac- -G0/G2- -G1- 1:1 Lys- 1 Ac- -G0/G1- -G2- 1:1 0 Lys- 1 Ac- — -G1- 1:1:1 1 Lys- G0/G1/G2- 1 Ac- - -G0/G1- -G0/G1- 1:2:1 2 Ly
- the resin was split to a 96 well ACT 496 Teflon reaction block.
- the resin was swelled with DMF and drained. 1 mL of 1.0 M amine solution in dimethylsulfoxide (DMSO) was added to each well. The reaction ran overnight. The resin was drained and washed twice with DMF, once with DMF:methanol:water (1:1:1), and washed three more times with DMF. The 24 lots of resin were then combined and split back to 24 wells.
- DMSO dimethylsulfoxide
- a second reductive amination was run using sodium triacetoxyborohydride.
- 350 ⁇ L of aldehyde solution (3.0 M/MMF) was added to each well and mixed for 2 minutes.
- An additional 250 ⁇ L of trimethylorthoformate was added to each well and mixed for 1 minute followed by 100 ⁇ L of 3% acetic acid in DMF.
- the reaction mixed for 15 minutes before a final addition of 1 mL of 1.5 M NaBH(O 2 CCH 3 ).
- the reaction ran overnight.
- the resin was drained and washed twice with DMF, three times with DMF:methanol:water, three times with DCM, and three final times with methanol.
- the reaction screening is performed on the ligand portion of the molecule where 3 different monomers were used for the coupling of primary amines to allylic bromides as well as 4 different reaction conditions to give a total of 12 combinations.
- the acylation of secondary amines with carboxylic acids involved 4 different acids and 4 different reaction conditions to give another 16 combinations.
- the resin was pooled and treated with 36 different conditions for the final intramolecular Heck reaction to give over 6900 potential compounds that contains different monomers and reaction conditions.
- TFA/MeCl 2 and 6% triethylene both the encoded portion and the ligand are liberated as outlined above.
- the ligand is also encoded by the incorporation of glycine(0) and glycine(2) to help identify the ligand peaks in the mass spectrum.
- the ratios generated for the simultaneous coupling are defined R1:R2:R3 and were as follows for the 16 samples: #1-1:1:5; Sample #2-1:2:5; Sample #3-1:3:5; Sample #4-1:4:5; Sample #5-2:1:5; Sample #6-2:2:5; Sample #7-2:3:5; Sample #8-2:4:5; Sample #9-3:1:5; Sample #10-3:2:5; Sample #11-3:3:5; Sample #12-3:4:5-Sample #13-4:1:5; Sample #14-4:2:5; Sample #15-4:3:5; Sample #16-4:4:5. Spectra for these ratios is shown in the accompanying FIGS.
- the beads themselves generally used as solid supports in solid state synthesis can be isotopically doped.
- Styrene beads comprised of styrene can readily by doped with C 13 , F 20 or H 2 . Additionally, it is possible to combine isotopically doped constructs with beads that have themselves been coded or tagged with one or more of a series of monomers.
- Styrene (M s ), 2-Fluorostyrene (M 1 ), 3-Fluorosytrene, (M 2 ) and 4-Fluorostyrene (M 3 ) were deinhibited prior to polymerization by passing through an alumina adsorption column.
- a 1000 component library consisting of three monomer positions was designed to demonstrate the utility of the encoding strategy.
- the library was synthesized using the split-mix methodology to create a 10 ⁇ 10 ⁇ 10 library. Since the split mix method yields one compound per bead and the beads are mixed twice during the synthesis, the chemistry or monomer addition at each step must be recorded on the bead in order to decode the compound.
- the first position is encoded by controlling the ratio of 12 C: 13 C 2 incorporated with bromoacetic acid in the first synthetic step. Ten unique ratios were employed with nine percent increments ranging from 9:91 to 90:10. The use of nine percent increments avoided the endpoints of either 0:100 or 100:0 while allowing a total of ten codes.
- the third monomer was alreacy known because the library was not recombined after addition of the final monomer (only one monomer from set three was present in each pool.) This position was therefore pool or spatially encoded.
- the second position was encoded by the molecular weight of the compound. Since monomer one is known by the isotopic reaction and monomer three by the final pool, monomer two can be calculated using the molecular weight determined by the mass spectrometer. This imposes one constraint for any library: the monomers in the second position must have different molecular weights. The other monomers have no restrictions.
- the final pools were composed of compounds having unique molecular weights in order to facilitate decoding.
- Mass spectral data from a single bead in pool 3 showed that M 0 H + and M 2 H + were 552 and 554, respectively.
- the M 0 H + :M 2 H + ratio was calculated to be 10:90, which was quite close to the actual ratio for ion 552, which was 9:91.
- M 0 H + as 550 and M 2 H + as 552 the calculated M 0 H + to M 2 H + ratio was 56:44.
- the compound having a M 0 H + ion in pool 2 had a theoretical of 54:46, again in very close agreement to the calculated ratio. In some cases, side-reactions involved in the addition of monomers may complicate the spectra.
- Spectra 2C shows the mass spectrum of a single bead from pool 1.
- the most intense ion in the spectrum is at m/z 586.
- the calculated M 0 H + :M 2 H + ratio (65:35) does no agree with known ration for the compound in pool 1 with M 0 H + of 586.
- This apparent discrepancy is due to the addition of the third monomer for pool 1, a nitrile. It is known that under acidic conditions (cleavage conditions) nitriles can be hydrated to an amide. With the addition of water, the peaks for the M 0 H + ion at 586 shift to 586 (M 0 H + 18).
- the M 0 H 30 :M 2 H + ratio for the peaks at 586 and 588 verifies the encode for the ion at 568 (which has its own, weaker set of peaks having the same ratio.).
- the known ration for the compound in pool 1 with a M 0 H + ion of 568 is 63:37, which corresponds to the calculated value. This particular hydration reaction was observed for all compounds in pool 1. This example demonstrates the ability to decode compounds and determine side reactions, a powerful enhancement over other encoding methodologies which would be very useful during solid phase chemistry development.
- step 5 compare the theoretical distribution from step 3 with the measured values in the mass spectrum using a Chi-Square test. The outcome of the Chi-Square determines the presence or absence of the encoded compound.
- This invention is executable on a MacIntosh computer or a IBM-PC compatible computer, running the Windows 95, Windows NT or Macintosh OS operating system, which includes a CPU, main storage, I/O resources, and a user interface including a manually operated keyboard and mouse.
Abstract
The insertion of isotopically labeled portions into solid state combinatorial synthesis constructs followed by mass spectrometer, mass-based nuclear magnetic resonance spectrometry or mass-based infrared spectrometry analysis allows for the physical, non-chemical encoding of large numbers of combinatorial synthesis products.
Description
- A portion of the disclosure of this patent document contains material which is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure, as it appears in the Patent and Trademark Office patent files or records, but otherwise reserves all copyrights whatsoever.
- The present invention generally relates to the field of combinatorial chemistry and in particular relates to encoding the library products of combinatorial synthesis.
- Recent trends in the area of research for novel chemical and especially pharmacological agents have been concentrated on the preparation of so-called “chemical libraries” as potential sources of new leads for drug discovery. Chemical libraries are intentionally created collections of differing molecules which can be prepared either synthetically or biosynthetically and screened for biological activity in a variety of different formats. One can have libraries of soluble molecules; libraries of compounds tethered to resin beads, silica chips or other solid supports; or recombinant peptide libraries displayed on bacteriaphage or other biological display vectors. Chemical libraries are advantageously made by using techniques from the field of combinatorial chemistry. The field of combinatorial chemistry is a synthetic strategy which leads to large chemical libraries. Combinatorial chemistry can be defined as the systematic and repetitive covalent connection of a set of different building blocks of varying structures to each other to yield a large array of diverse molecular entitites.
- Traditionally, new medicinal chemical lead structures have originated from the isolation of natural products from microbiological fermentations, plant extracts, and animal sources; from screening of pharmaceutical company compound databases; and more recently through the application of both mechanism-based and structure-based approaches to rational drug design. All of these methods are relatively expensive. Recent cost studies suggest that the average cost of creating a new molecular entity in a major pharmaceutical company is around $7,500 per compound, using the traditional chemical synthesis technology that requires more or less constant hands-on manipulation of reagents and apparatus and the attention of a chemist. Furthermore, the advent of high throughput automated techniques has made possible the robotized screening of in excess of hundreds of thousands of individual compounds per year, per drug target. The availability of this capability, combined with the relatively high cost of more traditional hand crafted chemistry has caused a global shift in emphasis toward the concept of mass production, which is an industrial concept that can be put into being using the approach of combinatorial chemistry.
- The inefficiencies of hand crafted chemistry are thus largely addressed by a switch to the concept of using combinatorial chemical technologies for rapidly synthesizing compound collections. Thus, by employing a building block approach and by systematically assembling these blocks in many combinations using chemical procedures it is possible to create chemical libraries as vast populations of molecules. An essential starting point for the generation of molecular diversity is an assortment of small, reactive molecules which may be considered chemical building blocks. The universe of structural diversity accessible through assembly of even a small set of building-block elements is potentially very large, and unleashing the power inherent in the building block approach is crucial to the success of the combinatorial method. The building block argument is easily illustrated as follows. Theoretically, the number of possible different individual compounds, N prepared by an ideal combinatorial synthesis is determined by two factors; the number of blocks available for each step “B” and the number of synthetic steps in the reaction scheme, s. If an equal number of building blocks are used in each reaction step, then N=BS. If the number of blocks that one desires for each step varies (e.g. b, c, d in a three-step synthesis), then N=bcd.
- From the above, it can be seen that a relatively conservative combinatorial synthesis procedure involving 20 blocks in a three step synthesis process will produce 203=8000 compounds. This relatively generous production output then raises the next question, which is, how will the compounds be identified? For example, a typical combinatorial synthesis technique is that of the split synthesis. As an example of split synthesis in the solid state synthesis of peptides, a batch of resin support (typically small resin beads) is divided into n fractions, coupling a single monomer amino acid to each aliquot in a separate reaction, and then throroughly mixing all the resin particles together. Repeating this protocol for a total of x cycles can produce a stochastic collection of up to nx different molecules, as governed by a hypergeometric distribution. To ensure representation of the majority of possible ligands one needs to begin with a multiplicity of beads. A typical value would be ten times as many beads as the desired number of ligands. Theoretically a set of every possible combination of the building blocks exists in, the aliquots. In order to determine the composition of a particular compound which is found to be of interest, one could proceed with direct ligand structural analysis, preferably on a mass spectrometer, on a species-by-species basis. A typical combinatorial synthesis now typically takes place on a reaction plate having from 96 to 2,304 reaction wells. One identifies the product compounds of true interest by a positive response in an appropriate assay. However, even after assays are run that will greatly reduce the number of compounds as having been non-active in the assay, the problem with a conventional mass spectrometer analytical approach is that many individual analysis trials are required, there may only be very small quantities of material available after running a combinatorial synthesis, and overall turn around time may be quite lengthy. A need exists, then to somehow label compounds as they are going through their combinatorial steps. Where compounds are, for example, tethered to resin beads, prior art solutions to the problem have included attaching chemical identifier tags to the beads coincident with each block coupling step in the synthesis. The different chemical properties of each tag would then convey which building block was coupled in a particular step of the synthesis, and the overall structure of a ligand on any bead could be deduced by “reading” the set of tags on that bead, in effect having encoded the bead.
- Tags should ideally have a highly discrete information content, be amenable to very high sensitivity detection and decoding, and must be stable to reagents used in the ligand synthesis. Prior art tags attached onto beads have included nucleotides, peptides, or a combined series of hydrocarbon homologs and polychlorinated aromatics. Single stranded oligonucleotides are built on resin beads upon which peptide synthesis is being performed and which are subsequently amplified through polymerase chain reaction and sequenced. Another technique is one where orthogonally differentiated diamine linkers are used in the construction of soluble chimeric peptides comprising a “binding” strand and a “coding” strand. As amino acid monomer building blocks are coupled to the binding strand, this is recorded by building an amino acid code onto the “coding” strand. The sequence of the coding strand is then resolved by Edman degradation. One problem with, this approach is that it requires an extra chemical step for every step taken in the construction of the library. Another problem with this approach is that it requires requires orthogonal synthetic procedures for building up a tag in conjunction with synthesis of ligands, i.e., it requires the addition of like moieties, whereas there is very great interest in discovering methods for producing compounds which are not limited to sequential addition of like moieties. Such methods would find application, for example in the modification of steroids, antibiotics, sugars, coenzymes, enzyme inhibitors, ligands, and the like, which frequently involve a multi-stage synthesis in which one would wish to vary the reagents and/or reactions conditions to provide a variety of compounds. In such methods the reagents may be organic or inorganic reagents, where functionalities may be introduced or modified, side groups attached or removed, rings opened or closed, stereochemistry changed, and the like. For such a method to be viable, however, there needs to be a convenient way to identify the structures of the large number of compounds which result from a wide variety of different modifications.
- A technique that is useful for the screening of nonsequenceable organic molecules prepared by multistep combinatorial synthesis uses a series of gas chromatographically resolvable halocarbon derivatives as molecular tags which, when appended to reactive groups on the bead surface, can constitute a binary code that reflects the chemical history of any member of a library. Instead of the oligonucleotide or peptide coding approaches where the order of assembly of the chemical building blocks for any library member is preserved in the sequence of a single cognate tagging molecule, the binary strategy uses a uniquely defined mixture of tags to represent each building block at each particular step of the synthesis. Thus a set of N tags can be used to encode the combinatorial synthesis of a library of 2N different members. After assembly, the tags are photolysed and analyzed by electron capture capillary gas chromatography.
- In all cases, the use of reporter tags complicates synthetic strategies, increases the risk of side reactions and by-products, and yields only indirect evidence of structure. Thus, there is a need to find a way whereby a compound's reaction history may be recorded, and the structure of the resulting compound identified.
- The use of13C site-specific labels on the-ligand itself has also been used, in connection with 13C NMR spectroscopy as a method of monitoring progress in solid state combinatorial synthesis.
- Yet another method is that of using a chip which allows for separate analysis at physically separate sites on the surface of the chip. By knowing what reactant is added sequentially at each such site, one can record the sequence of events and thus the series of reactions. If one then subjects the chip to a screening method for a particular desired characteristic and detects the characteristic one can readily determine the compound synthesized at the site which demonstrates that characteristic.
- A discrete sample-by-sample analysis will yield a great deal of extraneous information, as everything in the sample will be analyzed. However, in analyzing the results of a combinatorial synthesis, it is desirable to be able to track in linear terms, since all that is being tracked by a linear method is what is being added to the construct of interest in the synthesis, which will omit the presence of solvents, resin bits, side reactions and impurities.
- In view of the above needs and shortcomings of the prior art, it is a primary object of the present invention to reduce the amount of time needed to read and de-code the products of a combinatorial synthesis. It is another object of the present invention to provide a method of encoding combinatorial constructs that does not require orthogonal chemistry, that is, chemistry that has been carefully selected so as not to be interfering with the chemistry that is being executed as part of the combinatorial synthesis itself. Another object of the invention is to minimize the amount of capital investment needed to develop a coding strategy that requires no more than what is needed to initially develop a set of appropriate solid support links.
- Unlike the methods of the prior art, the present invention embodies a method of isotopically rather than chemically encoding a monomer to read a synthetic history. Readable differences in the encoding moieties therefore rely on physical differentiation, rather than chemical differentiation. The isotopically encoded monomer is, however, chemically bonded to the ligand of interest during-synthesis, in contrast to prior art identification methods in which differentiable isotopes are physically mixed into and interspersed with bulk chemicals or commodities to identify their, manufacturing source. The invention likewise does not rely on tagging a molecule, like other prior art approaches.
- FIG. 1 is an array of MS peaks that represent the observed peak signatures for the doped glycine code blocks described in the specification below.
- FIG. 2 is a graph that shows the observed correlation between number of carbon atoms present and the fraction of link content that has N15 present. The chart can be used to calculate equal intensity peak signatures.
- FIG. 3 illustrates a two peak positional coding strategy for a molecule, featuring splitting MS peaks into doublets to enhance code recognition.
- FIG. 4 illustrates the observed correlation between MS peak area and ratio of N15 present in a code sample for a series of code samples differing in N15 content by 5% increments.
-
- denoting that 55% of the carbon at the penultimate position was doped with C13.
-
- denoting that 60% of the carbon at the penultimate position was doped with C13.
-
- denoting that 75% of the carbon at the penultimate position was doped with C13.
-
- denoting that 80% of the carbon at the penultimate position was doped with C13.
- FIG. 9 is a chart that correlates the observed ratio of C13 to C12 in the NMR spectra of FIGS. 5 through 8 with the % of C13 present in each.
- FIGS. 10 through 12 show spectra observed in conjunction with the Example 23 procedure on the Reaction Screening embodiment of the invention.
- FIGS. 13 through 17 show synthesis flow diagrams used in the Example 23 disclosure on the Reaction Screening embodiment of the invention.
- FIGS. 18 through 51 show, spectra observed in conjunction with the Example 24 disclosure of the Ratio Coding embodiment of the invention.
- FIGS. 52 through 110 show spectra that are produced in conjunction the disclosure of Example 25 of encoding styrene and Example 26 disclosing copolymerization of styrene and F-styrene.
- FIGS. 111 through 132 show spectra representing the decoding of a parallel synthesis of a library on encoded resin beads, using a dual linker approach in which a first linker was a photocleavable linker and a second linker was a Knorr linker.
- FIGS.133 to 286 are spectra that are produced by a set of code blocks organized in a type of ratio encoding designated as four peak ratio encoding, using four isotopically distinct F-moc protected versions of alanine
- FIG. 287 is a flow diagram for a computer program capable of automating the decoding of a set of code blocks and their associated spectra.
- In brief summary, the invention is the application of mass or isotopic encoding in the imprinting of coded information into or in conjunction with materials or processes shch that the details of the components or process steps can be easily determined by one or more of the methods of mass spectrometry, nuclear magnetic resonance spectroscopy, or infrared spectroscopy, including the technique of Ramen spectroscopy. In a preferred embodiment, the invention is a method of encoding the products of combinatorial synthesis by isotopically doping a portion of a combinatorial chemistry construct and analyzing the combinatorial reaction products by mass spectrometry, nuclear magnetic resonance spectroscopy or infrared spectroscopy.
- In overview, the invention comprises several embodiments. Firstly, the invention comprises a mass-based, non-chemical method for recording the reaction of at least a portion of a reaction series on each of a plurality of unique solid supports, the method comprising: preparing a plurality of agents each having a unique defined mass; preparing a group of unique solid supports; reacting each solid support group with a different chemical reagent under a controlled reaction condition; mixing these product groups together and then dividing the mixture of unique solid supports into a plurality of groups for a second intermediate or final stage; repeating the reacting stage with a chemical reagent under a controlled reaction condition at least once to provide a plurality of final products, having different products on the different individual unique solid supports; each of the unique defined mass agents being reacted with either: each of a group of unique solid supports; each of a group of first chemical reagents in a reaction series; each of a group of second chemical reagents in a reaction series; or each of a group of subsequently added chemical reagents in a reaction series; such that each of the group of unique solid supports, group of first chemical reagents, group of second chemical reagents or group of subsequent chemical reagents has been reacted with an agent having a defined mass that is different from any other defined mass agent reacted with any other of the aforesaid groups; the unique defined mass agents being capable of being analyzed and wherein such analysis defines the choice of a first chemical reagent, reaction condition under which the first chemical reagent was added, second chemical reagent, reaction condition under which the second chemical reagent was added, subsequent chemical reagent, or reaction condition under which the subsequent chemical reagent was added. The method is particularly preferred in performing an assay or using separation techniques including column or plate chromatography or fluorescence assistance cell scanning to find reaction products having a characteristic of interest and then performing the identification analysis on such reaction products. This method is particularly preferred with respect to the determination of the first chemical reagent added to the reaction sequence. Reaction products can include a non-oligomer which is aliphatic, alicyclic, aromatic, or heterocyclic or an oligomer which is an oligopeptide, oligonucleotide, oligosaccharide, polylipid, polyester, polyamide, polyurethane, polyurea, polyether, polyphosphorus derivative where the phosporus is taken from the group consisting of phosphate, phosphonate, phosphoramide, phosphonamide, phosphite, or phosfinamide, or polysulfur derivative where the sulfur is taken from the group consisting of sulfone, sulfonate, sulfite, sulfinamide, or sulfenamide.
- Preferred means of analysis are by mass spectrometry (MS), nuclear magnetic resonance (NMR) spectroscopy, and infrared or Raman spectroscopy. These means of analysis produce distinctive peak patterns used in analysis, identification, coding and decoding strategies. The mass spectrometer in particular produces unique single mass peaks, unique double mass peaks, unique pairs of single mass peaks, unique pairs of double mass peaks and other unique multiple peak patterns, which are additionally capable of being translated into machine-readable patterns, including bar codes. The NMR, IR and Raman methods also produce useful unique peak patterns that can be transformed into machine-readable patterns, including bar codes. Such patterns, including machine-readable patterns, can be assigned in encoding strategies to represent discrete chemical reagents added in a chemical reaction series, or assigned to represent discrete chemical reaction conditions under which a chemical reagent was added in a reaction series, including, but not limited to, concentrations, temperatures, pressures, catalysts, enzymes, electromagnetic energy imparted to the system (visible light conditions, irradiation, etc.), and so on. This is done by initially generating recognition patterns for unique mass defined agents which are either eye-readable or machine-readable. The patterns resulting from the analysis steps are then compared to the recognition patterns for identification and decoding, with or without the assistance of a machine. Recognition patterns and analysis patterns that are machine-readable are capable of being stored electronically in suitable computer storage and memory devices well known to those of ordinary skill in the art and such stored patterns form a readily retrievable database that also forms a claimed embodiment of the invention.
- Mass agents used in these methods are preferably a molecular entity such as a solid state chemistry support resin bead linker which has had one or more of its atoms replaced by an isotope of that atom, thus altering the mass, but not the chemical properties of that chemical entity. Another alternative mass agent is to simply repeat the appearance of such a molecular entity an integral number of times in a linear chemical construct.
- The method of the invention can be performed using solid state chemistry or solution chemistry. Reaction products can be cleaved off of a solid support for analysis, or the entire construct can be analyzed. Chemical reagents added to a reaction series can include one or more that can act as a substrate for the determination of binding specificity to a chemical compound of interest. Any or all of the steps of encoding, synthesis, analysis and decoding can be automated with the aid of suitable computer means and robotics means, all by methodologies well known to those of ordinary skill in the combinatorial chemistry, spectroscopy, computer science, robotics and optical scanning arts.
- The invention also comprises a kit made up of a set of compounds prepared for the encoding, synthesis, analysis and decoding methods described above of chemical reagents and reaction conditions in chemical reactions of interest in a combinatorial synthesis, where the compounds in the kit have different distinguishable masses, but the same chemical properties. Such kits can comprise solid state supports attached to isotopically doped linkers, series or combinations of isotope mixtures in readily identifiable ratios, or a variety of combinations of isotopically doped chemical moieties (also called code blocks herein) with covalent bonds or or other organic moieties as links or linkers.
- The invention also comprises kits of solid state supports that have been prepared so as to bear unique defined mass agents on their surface. Solid supports can be resin beads in a wide range of sizes of from 1 to 10,000 μm in dimension. The support itself can be isotopically doped by incorporating an isotope into the chemical structure of the support. This differentiates the mass of the support from like supports, but does not change its chemical properties. Such solid supports would then be used in the methods of the invention. Groups of such uniquely mass-defined supports can comprise libraries, which are also an embodiment of the invention as claimed herein.
- The term “isotopic doping” or “isotopically doped” is used here to mean the introduction, into a molecule of an isotope of one or more of the atoms normally appearing in that molecule.
- A “link” is a covalent bond or a molecular moiety that is suitable for linking two portions of a construct together.
- A “linker” is a moiety comprised of a code block, a first link for bonding the code block to a solid support or other moiety, and a second link for bonding the code block to a ligand or other moiety.
- A “linker mix” is a mixture of two isotopically distinct but chemically identical molecules, the mix having a discrete ratio of first isotope to second isotope.
- A “code block” is a molecule or series of molecules containing one or more isotopically doped atoms or having a repeating number of molecules in series, such that its mass can be discretely defined and differentiated from any other code block.
- A “doped” atom, code block or moiety refers to an entity in which an atom in a molecule which has been replaced by one of its isotopes. Doped atoms as contemplated by this invention include all atoms found in organic chemistry having isotopes and in particular, hydrogen, carbon, nitrogen, fluorine and oxygen. Non-radioactive isotopes are generally preferred over radioactive ones.
- The term “monomer” is used herein not only to denote subunits that make up a linear molecules such as amino acids, but also to denote starting chemical materials and chemical reagents that are chemically reacted with one another in combinatorial chemistry organic synthesis to produce molecules that are not linear, such products including so-called “small molecules” which are organic molecules of 500 Daltons or less in molecular weight. As used herein, the terms “monomer” and “chemical reagent” are interchangeable.
- A “reaction series” as used herein refers to a series of steps in a chemical synthesis in a combinatorial synthesis format.
- A “solid support” is one or materials upon which combinatorial chemistry syntheses can be performed, including beads, solid surfaces. solid substrates, particles, pellets, disks, capillaries, hollow fibers, needles, solid fibers, cellulose beads, pore-glass beads, silica gels, polystyrene beads optionally crosslinked with divinylbenzene, grafted co-polybeads, poly-acrylamide beads, latex beads, dimethylacrylamide beads optionally cross-linked with N,N′-bis-acryloyl ethylene diamine, glass particles coated with a hydrophobic polymer, fullerenes and soluble supports such as low molecular weight non-cross-linked polystyrene.
- A “construct” is a covalently bonded entity comprising, in any combination, some type of solid support, one or more linkers, one or more code blocks, and one or more ligands.
- A “ligand” is a chemical reaction product of interest. A ligand can be part of a larger construct, where the ultimate goal will be to identify and/or cleave the ligand apart from the rest of the construct.
-
- Isotopes are inserted into such constructs via doped links. That is, after the determination has been made as to what will constitute a chemically suitable link, the link is synthesized using one or more atoms of the link that has been substituted by an isotopic form of that atom. The isotopic form is chemically indistinguishable from the non-isotopic form of the link. The isotopic form is, however physically distinguishable from other isotopic forms by MS or NMR analysis. This physical difference is manifested by differently appearing MS, IR, or NM R peak patterns. A wide variety of isotopic insertion or doping strategies are available, leading to a large number of physically distinguishable chemical moieties, each having its own distinctive peak pattern. The existence of such distinctive peak patterns means that the isotopic forms can be used to create a code that can be used in various encoding strategies to readily identify different chemical entities or conditions that can be used during a combinatorial synthesis. Several of such encoding strategies are given below.
- Electrospray mass spectrometry provides mass and ionic charge intensity information for a given molecular entity. In general, smaller molecules only appear in the spectrum once as singly charged species, and the effect of isotopic compositional variation results in a very predictable quantum mass shift. Thus, for example, a molecule having a molecular weight of 304 will produce a peak at 305 (M+1) on a mass spectrometer (MS) spectrum. If a nitrogen atom in such molecule having an atomic weight of 14 (N14) is replaced (by isotopic doping, as that term is used herein) by isotope N15, then the MS peak will shift to the right precisely one unit to 306. Furthermore, such isotopic doping will not affect the ionization or chemical reactivity of the molecule. The ability to measure both of the properties of mass and ionic intensity with reasonable accuracy (i.e. mass to about 0.1 atomic mass units and relative intensity to about 3% provides the basis for a novel encoding strategy using isotopes to isotopically, rather than chemically, encode a monomer to read a synthetic history, instead of tagging a molecule itself. Using the methods of the invention, encoding strategies are devised from the use of the mass information alone, the relative intensity information in two or more mass peaks alone or a combination of the two. The basic methodology of the invention, which is to insert different isotopes into combinatorial constructs to identify addition of monomers or chemical conditions, gives rise to several alternative embodiments for encoding and decoding, which are capable of individual implementation or in selected combinations.
- Multiple preferred coding approaches using defined mass agents will be discussed. These examples are non-limiting and other coding approaches are not meant to be excluded.
- In a most preferred embodiment of the invention, a series of isotopically doped linker mixes n is prepared, with each linker mix in the series comprising a discrete ratio of first isotope to second isotope, and with each mix in the series differing in ratio from the previous or subsequent mix in the series by an equal amount. Thus, for example, a series of 21 batches of doped monomer can be prepared, with the first batch in the series having a-ratio of 100% of first isotope to 0% of second isotope, the second batch having a ratio of 95% of first isotope to 5% of second isotope, and so on until the 21st batch, which will have 0% of first isotope and 100% of second isotope. Each linker is further characterized by being capable of being cleaved such that one cleavage portion will always contain the isotopically doped molecular moiety. Each linker mix is chemically reacted with a support means on one side of the linker to yield n batches of support-linker, again each having a discrete ratio of first to second isotope. Then a reagent of interest is added to each batch to yield n batches of support-linker-molecule, each likewise having the discrete ratios of two isotopes. If, now for example, a split synthesis method is being pursued, then the n batches are combined into a single mixing vessel and the resulting mix is then divided into n aliquots, and to each aliquot is added a second reagent of interest, and the resultant reactions are allowed to proceed. The previous step of combining all aliquots and then splitting them out into n aliquots is repeated, and a third reagent of interest can be added. If all possible reactions have proceeded to completion, then there are now n3 products. The linkers can be cleaved so that the isotopically labeled fragment stays with the chemical product, and the resulting isotope label-chemical product construct is analyzed by a mass spectrometer. The resulting mass spectrogram will display a peak pattern that mirrors the ratio of first isotope to second isotope present in the linker fragment, thus identifying what the first chemical reagent was that was added to that particular reaction well. Thus, for example, if the isotope ratio is 100% for first isotope to 0% for second isotope, then one relatively tall peak will appear on the spectrogram at the position on the spectrum occupied by -the discrete atomic mass that that moiety has (as will be appreciated by those of ordinary skill in the art, other relatively small peaks, will, of course appear, but just one prominent peak that is characteristic of the molecule as used in the identification method of the present invention appears.). If the isotope ratio is 95% of first isotope to 5% of second isotope, then there will be a first prominent peak and a second prominent peak, with the first prominent peak having about 95% of the total area under the combined prominent peaks, and the second prominent peak having the remaining approximately 5%, thus forming a distinct prominent peak pattern which serves to clearly identify the isotope ratio and therefore the chemical reagent. It is to be understood that another smaller peak not part of the patterns forming the codes of the invention will-appear, by virtue of the natural abundance of C13, and its relative size can be predicted using the following analysis. If a given moiety contains 24 carbons and nitrogen and it has been doped to a 50/50 ratio of N14/N15, then peak 1 will be calculated from the N14/C12 present as (0.898)24×0.5=0.383;
peak 2 will be calculated from the N15/C12 and N14/C13 present as (0.989)24×0.5+(0.989)23 (0.011)×24×0.5=0.485; and the third peak will be calculated from the N15/C13 present as (0.989)23 ×(0.011)×24×0.5=0.102, thus resulting in a distinctive pattern having two approximately equal prominent peaks, and the relatively small side peak. Ideally, the isotopically distinct species used should differ by two or more AMUs as this would produce well separated peaks that would not be affected by the natural presence of 13C. To achieve this with the atoms that are most commonly used in such chemistry (C,H,N,O) typically requires that more than one atom be isotopically substituted, as available stable isotopes of C, H and N differ by only one mass unit. - Subsequently, in order to identify the third component in the combinatorial construct, the third component can be identified by its reaction well number. Now, with the identity of the first component known by virtue of the mass spectrograph and the third component known by virtue of the well number, their combined molecular weights are subtracted from the total molecular weight of the construct to arrive at a residual mass which identifies the second component of the construct.
- It should be appreciated that using the methods and constructs of the invention provide for an entire series of encoded linkers that provide great economic savings, since the only additional synthesis initially required is to isotopically dope a solid support linker that had to constructed in the first place. No other chemical modifications are needed to be made to the linkers that were initially chosen for the solid state combinatorial synthesis.
- For syntheses having more than three steps, the procedure of Ratio Coding described above is followed in that a series of isotopically doped linker mixes n is prepared, with each linker mix in the series comprising a discrete ratio of first isotope to second isotope, and with each mix in the series differing in ratio from the previous or subsequent mix in the series by an equal amount. However, a second type of atom is also isotopically doped, so that there are two types of atomic isotopes present. For example a nitrogen position can be doped with a mix of N14 and N15, while a carbon position can be doped with a mix of C12 and C13. Again, this example will follow the progression of 5% increments, so that there are 21 possible nitrogen ratio combinations and 21 possible carbon ratio combinations. Furthermore, the carbon position is protected with a suitable protecting group, which can be deprotected to correlate to a reaction step in the combinatorial synthesis. Thus, the mass spectrograph peak pattern for the doped nitrogen identifies the first synthesis component, the mass spectrograph peak pattern for the doped carbon identifies the second synthesis component, an assay identifies the fourth component, and the third component is identified by subtraction of the first, second and fourth components from the total weight of the product.
- Occasionally, code degeneration may arise when using more than one type of isotope, as in the case where one moiety bore a N15-C12 combination and another bore a N14-C13 combination, both of which would have the same atomic weight and therefore give indistinguishable peak patterns in a mass spectrograph. This problem can be circumvented in one of two general ways. Firstly, by selecting C12 and C14 as the carbon isotope pair, this type of code degeneracy is avoided. Or, if radioactivity is to be avoided, C12 and C13 can still, be used by the technique of combining mass spectrography with fragmentation. For example, an amide moiety of the structure
- CH3—NH—CO—CH2—CH3
-
- However, when they are fragmented along the indicated cleavage lines, moiety I will yield a fragment having a doped N and a normal C, while moiety II will yield a fragment having, a doped C and a normal N, thereby yielding distinctive peak patterns in the MS.
- The following scheme illustrates the Single Peak Positional Coding Approach
-
- Following the process in
Scheme 2, another alternative embodiment of the invention of isotopic encoding can follow a single MS peak position approach. This approach generates a MS peak. In this format, the mass of the coding block is engineered such that it appears in a convenient part of the spectrum, and it is used to represent the first monomer or building block used in the synthesis of a particular compound. After the combinatorial synthesis is complete,Link 2 is cleaved in order to determine the molecular weight of the ligand. ThenLink 1 is cleaved to enable identification of the Code block, which determines the identification of the first pool monomer. - The first and second links in a linker scheme can be the same or different. The links can be the same when a direct binding assay is used, followed by removal of positive beads. When the links are different, this allows the assay to be either by direct binding or with cleaved ligand alone.
- Decoding of a three monomer combinatorial- library is achieved from three steps. The mass of the code block is determined, thus identifying the code, which identifies the first pool monomer. The pool number of the final monomer addition determines the final monomer, from which the mass of the final monomer is known. Then, the masses of the first and third pool monomers are subtracted from the total molecular weight of the entire construct, thus leaving the mass of the second pool monomer, from which the identity of the second pool monomer is inferred.
- The Single Peak Positional encoding approach is especialy useful when active ligands are screened by use of a chromatography column, and the, bound constructs are then eluted.
- The following scheme illustrates the Double Peak Positional Coding Approach
-
- Following the process in
Scheme 3, another alternative embodiment of the invention of isotopic encoding can follow a double MS peak position strategy. This approach yields two MS peaks. For example, a set of resin beads is prepared wherein the beads bear two protected sites, such as BOC and FMOC. A first protected site is de-protected. A number of isotopic code blocks n is prepared and each code is linked to a first de-protected site. - The second, protected site is de-protected. A standard reference moiety having a different mass is linked to the second de-protected site. Upon MS, this will yield a peak for the standard reference and a second peak for the code, with the mass difference between the two peaks being the encoding unit. Decoding of a three monomer combinatorial library is achieved from three steps. The mass of the ligand plus code block is determined, thus identifying the code, which identifies the first pool monomer. The pool number of the final monomer addition determines the final monomer, from which the mass of the final monomer is known. Then, the masses of the first and third pool monomers are subtracted from the total molecular weight of the entire construct, thus leaving the mass of the second pool monomer, from which the identity of the second pool monomer is inferred.
- In an alternative construct, the code block is prepared to contain two like species, one of which is constant and acts as a reference mass, while the other has variable mass blocks similar to those described for the single peak positional encoding scheme. After cleavage of the link to the resin, ligand is generated with an attached variable code increment. The encoded information is now determined from the difference in mass of the coding unit and the reference mass unit. The advantage of this is that the code can be left attached to the ligand and read at the same time as the mass of the whole construct is determined by MS. This strategy gives two mass peaks that represent the ligand attached to either the reference code or the variable code. The difference in mass is used to determine the identity of
monomer 1, whilemonomer 3 known from the corresponding pool and thereforemonomer 2 is inferred as described above. - The invention also makes possible an alternative embodiment that in effect creates a bar coding mechanism. Several non-limiting exemplary versions of solid state constructs are possible as follows.
-
- In this approach and its variations, a code block most advantageously consists of a dimer, each of which unit has one, two or three discrete masses. For example a construct of the structure: contains a code block having two mass blocks, M1 and M2, which in this example will be comprised of one, two or three amino acids. The amino acids are doped to give three discrete masses yielding, for example, Glycine (G0), with a mass of 57, Glycine bearing N15 (G1) with a mass of 58 and Glycine bearing two Deuterium atoms (G2) at
carbon 2 with a mass of 59. Assembling these three moieties into 7 possible mass sets yields the following codes and their fractions of the total:Composition Relative Presence G 0 100 % G 1 100 % G 2 100% G0G1 50% and 50% G0G2 50% and 50% G1G2 50% and 50% G0G1G2 33.3%, 33.3% and 33.3% - It is now possible to assemble these mass sets into blocks M1 and M2 and to predict what the characteristic MS peak pattern will be for each code block. For this group of mass sets in
Version 1 of the Bar Coding Approach, the following MS peak pattern is predicted:Code Predicted Peak Sam- Pattern, (AMU) ple M1 M2 114 115 116 117 118 1 57 (G0) 57 (G0) 2 57 (G0) 57, 58 (G0), (G1) 3 57 (G0) 57, 59 (G0), (G2) 4 57 (G0) 57, 58, 59 (G0), (G1), (G2) 5 57, 58 57, 59 (G0), (G2) (G0), (G1) 6 57, 59 57, 59 (G0), (G2) (G0), (G2) 7 57, 59 57, 58, 59 (G0), (G2) (G0), (G1), (G2) - In this table, for code sample 1 a single peak is predicted at 114, since the combined masses of each G0 are 57+57=114. For
code sample 2, two equal peaks are predicted at 114 and 115, since G0 in M1 plus G0 in M2 adds up to 114, and G0 in M1 plus G1 in M2 adds up to 115. Incode sample 6, two single peaks are predicted at 114 and 118 and a redundancy is predicted at 116 to yield a peak approximately two times as tall as the peaks at 114 and 118. - In the following table, predicted MS peak patterns are shown for 25 code samples. The actual MS peak patterns are shown below the predicted peak pattern table, and it can be seen that there is excellent correlation between observed and predicted peak patterns. References to G0, G1 and G2 are omitted although the same three isotopically doped versions of Glycine described above are still being used in this table (Note that the numerical values for the MS in FIG. 1 are for the total mass of the entire construct, including a Lysine residue and the linkers, which fall into a range of 300 to 309 mass units)
Predicted Peak Code Pattern (AMU) Sample M1 M2 114 115 116 117 118 1 57 57 2 57 58 3 57 57, 58 4 57 59 5 57 57, 59 6 57 58, 59 7 57 57, 58, 59 8 58 59 9 58 57, 59 10 59 57, 58 11 58 57, 58, 59 12 57, 58 57, 58 13 57, 58 57, 59 14 57, 58 58, 59 15 57, 58 57, 58, 59 16 59 59 17 59 57, 59 18 57, 59 57, 59 19 59 58, 59 20 59 57, 58, 59 21 57, 59 58, 59 22 57, 59 57, 58, 59 23 58, 59 58, 59 24 58, 59 57, 58, 59 25 57, 58, 59 57, 58, 59 - Once the MS is run on a completed combinatorial synthesis sample, the pattern is compared to a predicted pattern, which in turn identifies the code, which in turn identifies the first pool monomer. The predicted patterns can form a type of machine readable bar code, which, using methods well known to those of ordinary skill in the optical scanning art, enables rapid data inputing, decoding and interpretation.
-
- where isotope doping occurs at the bead link and attached to the end of a three monomer ligand, as indicated by the asterisk. Isotope doping could also be performed at the other end of the ligand as well.
- In another alternative embodiment of the invention, since isotopes can be readily read by nuclear magnetic resonance (NMR), this can be used instead of, or in conjunction with, MS spectroscopy. NMR offers the advantages of greater accuracy (one can run ratio pools in increments of down to 1%), the bead does not have to be cleaved off of the construct prior to analysis, and that NMR, unlike MS, is non-destructive.
-
- FIGS.133 to 286 display spectragrams associated with another variation of ratio encoding, which is a four peak ratio encoding scheme. In the following table, the first column represents the code block, the second column is an internal reference number, and the third, fourth, fifth and sixth columns represent the respective mole fractions of FMOC-protected alanines with different integral masses using isotope doping, i.e. A0, A3, A2, and A1 (A is reference alanine, A3 is alanine plus 3 atomic mass units, A2 is alanine plus two atomic mass units, etc.).
1, 111, 0.56, 0.16, 0.16, 0.16 2, 112, 0.56, 0.16, 0.16, 0.21 3, 113, 0.51, 0.11, 0.11, 0.26 4, 114, 0.46, 0.11, 0.11, 0.31 5, 115, 0.46, 0.11, 0.11, 0.36 6, 116, 0.41, 0.11, 0.11, 0.41 7, 121, 0.56, 0.16, 0.21, 0.16 8, 122, 0.51, 0.11, 0.21, 0.21 9, 123, 0.46, 0.11, 0.21, 0.26 10, 124, 0.46, 0.11, 0.16, 0.31 11, 125, 0.41, 0.11, 0.16, 0.36 12, 126, 0.41, 0.11, 0.16, 0.41 13, 131, 0.51, 0.11, 0.26, 0.11 14, 132, 0.46, 0.11, 0.26, 0.21 15, 133, 0.46, 0.11, 0.26, 0.26 16, 134, 0.41, 0.11, 0.21, 0.31 17, 135, 0.41, 0.11, 0.21, 0.31 18, 136, 0.36, 0.11, 0.21, 0.36 19, 141, 0.46, 0.11, 0.31, 0.11 20, 142, 0.46, 0.11, 0.31, 0.16 21, 143, 0.41, 0.11, 0.31, 0.21 22, 144, 0.41, 0.11, 0.26, 0.26 23, 145, 0.36, 0.11, 0.26, 0.31 24, 146, 0.36, 0.11, 0.26, 0.36 25, 151, 0.46, 0.11, 0.36, 0.11 26, 152, 0.41, 0.11, 0.36, 0.16 27, 153, 0.41, 0.11, 0.31, 0.21 28, 154, 0.36, 0.11, 0.31, 0.26 29, 155, 0.36, 0.11, 0.31, 0.31 30, 156, 0.31, 0.11, 0.26, 0.31 31, 161, 0.41, 0.11, 0.41, 0.11 32, 162, 0.41, 0.11, 0.41, 0.16 33, 163, 0.36, 0.11, 0.36, 0.21 34, 164, 0.36, 0.11, 0.36, 0.26 35, 165, 0.31, 0.11, 0.31, 0.26 36, 166, 0.31, 0.11, 0.31, 0.31 37, 211, 0.56, 0.21, 0.16, 0.16 38, 212, 0.51, 0.21, 0.11, 0.21 39, 213, 0.46, 0.21, 0.11, 0.26 40, 214, 0.46, 0.16, 0.11, 0.31 41, 215, 0.41, 0.16, 0.11, 0.36 42, 216, 0.41, 0.16, 0.11, 0.41 43, 221, 0.51, 0.21, 0.21, 0.11 44, 222, 0.46, 0.21, 0.21, 0.21 45, 223, 0.46, 0.16, 0.16, 0.26 46, 224, 0.41, 0.16, 0.16, 0.31 47, 225, 0.41, 0.16, 0.16, 0.31 48, 226, 0.36, 0.16, 0.16, 0.36 49, 231, 0.46, 0.21, 0.26, 0.11 50, 232, 0.46, 0.16, 0.26, 0.16 51, 233, 0.41, 0.16, 0.21, 0.21 52, 234, 0.41, 0.16, 0.21, 0.26 53, 235, 0.36, 0.16, 0.21, 0.31 54, 236, 0.36, 0.16, 0.21, 0.36 55, 241, 0.46, 0.16, 0.31, 0.11 56, 242, 0.41, 0.16, 0.31, 0.16 57, 243, 0.41, 0.16, 0.26, 0.21 58, 244, 0.36, 0.16, 0.26, 0.26 59, 245, 0.36, 0.16, 0.26, 0.31 60, 246, 0.31, 0.16, 0.26, 0.31 61, 251, 0.41, 0.16, 0.36, 0.11 62, 252, 0.41, 0.16, 0.31, 0.16 63, 253, 0.36, 0.16, 0.31, 0.21 64, 254, 0.36, 0.16, 0.31, 0.26 65, 255, 0.31, 0.16, 0.26, 0.26 66, 256, 0.31, 0.11, 0.26, 0.31 67, 261, 0.41, 0.16, 0.41, 0.11 68, 262, 0.36, 0.16, 0.36, 0.16 69, 263, 0.36, 0.16, 0.36, 0.21 70, 264, 0.31, 0.16, 0.31, 0.26 71, 265, 0.31, 0.11, 0.31, 0.26 72, 266, 0.31, 0.11, 0.31, 0.31 73, 311, 0.51, 0.26, 0.11, 0.11 74, 312, 0.46, 0.26, 0.11, 0.21 75, 313, 0.46, 0.26, 0.11, 0.26 76, 314, 0.41, 0.21, 0.11, 0.31 77, 315, 0.41, 0.21, 0.11, 0.31 78, 316, 0.36, 0.21, 0.11, 0.36 79, 321, 0.46, 0.26, 0.21, 0.11 80, 322, 0.46, 0.26, 0.16, 0.16 81, 323, 0.41, 0.21, 0.16, 0.21 82, 324, 0.41, 0.21, 0.16, 0.26 83, 325, 0.36, 0.21, 0.16, 0.31 84, 326, 0.36, 0.21, 0.16, 0.36 85, 331, 0.46, 0.26, 0.26, 0.11 86, 332, 0.41, 0.21, 0.21, 0.16 87, 333, 0.41, 0.21, 0.21, 0.21 88, 334, 0.36, 0.21, 0.21, 0.26 89, 335, 0.36, 0.21, 0.21, 0.31 90, 336, 0.31, 0.21, 0.21, 0.31 91, 341, 0.41, 0.21, 0.31, 0.11 92, 342, 0.41, 0.21, 0.26, 0.16 93, 343, 0.36, 0.21, 0.26, 0.21 94, 344, 0.36, 0.21, 0.26, 0.26 95, 345, 0.31, 0.21, 0.26, 0.26 96, 346, 0.31, 0.16, 0.21, 0.31 97, 351, 0.41, 0.21, 0.31, 0.11 98, 352, 0.36, 0.21, 0.31, 0.16 99, 353, 0.36, 0.21, 0.31, 0.21 100, 354, 0.31, 0.21, 0.26, 0.26 101, 355, 0.31, 0.16, 0.26, 0.26 102, 356, 0.31, 0.16, 0.26, 0.31 103, 361, 0.36, 0.21, 0.36, 0.11 104, 362, 0.36, 0.21, 0.36, 0.16 105, 363, 0.31, 0.21, 0.31, 0.21 106, 364, 0.31, 0.16, 0.31, 0.21 107, 365, 0.31, 0.16, 0.31, 0.26 108, 366, 0.31, 0.16, 0.31, 0.31 109, 411, 0.46, 0.31, 0.11, 0.11 110, 412, 0.46, 0.31, 0.11, 0.16 111, 413, 0.41, 0.31, 0.11, 0.21 112, 414, 0.41, 0.26, 0.11, 0.26 113, 415, 0.36, 0.26, 0.11, 0.31 114, 416, 0.36, 0.26, 0.11, 0.36 115, 421, 0.46, 0.31, 0.16, 0.11 116, 422, 0.41, 0.31, 0.16, 0.16 117, 423, 0.41, 0.26, 0.16, 0.21 118, 424, 0.36, 0.26, 0.16, 0.26 119, 425, 0.36, 0.26, 0.16, 0.31 120, 426, 0.31, 0.26, 0.16, 0.31 121, 431, 0.41, 0.31, 0.21, 0.11 122, 432, 0.41, 0.26, 0.21, 0.16 123, 433, 0.36, 0.26, 0.21, 0.21 124, 434, 0.36, 0.26, 0.21, 0.26 125, 435, 0.31, 0.26, 0.21, 0.26 126, 436, 0.31, 0.21, 0.16, 0.31 127, 441, 0.41, 0.26, 0.26, 0.11 128, 442, 0.36, 0.26, 0.26, 0.16 129, 443, 0.36, 0.26, 0.26, 0.21 130, 444, 0.31, 0.26, 0.26, 0.26 131, 445, 0.31, 0.21, 0.21, 0.26 132, 446, 0.31, 0.21, 0.21, 0.31 133, 451, 0.36, 0.26, 0.31, 0.11 134, 452, 0.36, 0.26, 0.31, 0.16 135, 453, 0.31, 0.26, 0.26, 0.21 136, 454, 0.31, 0.21, 0.26, 0.21 137, 455, 0.31, 0.21, 0.26, 0.26 138, 456, 0.31, 0.21, 0.26, 0.31 139, 461, 0.36, 0.26, 0.36, 0.11 140, 462, 0.31, 0.26, 0.31, 0.16 141, 463, 0.31, 0.21, 0.31, 0.16 142, 464, 0.31, 0.21, 0.31, 0.21 143, 465, 0.31, 0.21, 0.31, 0.26 144, 466, 0.26, 0.21, 0.26, 0.26 - In the following table, each of the enumerated code blocks listed immediately above is correlated with a spectragram number identified in the second column and shown on the face of each respective spectra in the figures.
Spectra Code Block Identifying Number 1 ASA008683 2 ASA 008684 3 ASA 008685 4 ASA 008686 5 ASA 008687 6 ASA 008688 7 ASA 008689 8 ASA 008690 9 ASA 008691 10 ASA 008692 11 ASA 008693 12 ASA 008694 13 ASA 008695 14 ASA 008696 15 ASA 008697 16 ASA 008698 17 ASA 008699 18 ASA 008700 19 ASA 008701 20 ASA 008702 21 ASA 008703 22 ASA 008704 23 ASA 008705 24 ASA 008706 25 ASA 008707 26 ASA 008708 27 ASA 008709 28 ASA 008710 29 ASA 008711 30 ASA 008712 31 ASA 008713 32 ASA 008714 33 ASA 008715 34 ASA 008716 35 ASA 008717 36 ASA 008718 37 ASA 008719 38 ASA 008720 39 ASA 008721 40 ASA 008722 41 ASA 008723 42 ASA 008724 43 ASA 008725 44 ASA 008726 45 ASA 008727 46 ASA 008728 47 ASA 008729 48 ASA 008730 49 ASA 008731 50 ASA 008732 51 ASA 008733 52 ASA 008734 53 ASA 008735 54 ASA 008736 55 ASA 008737 56 ASA 008738 57 ASA 008739 58 ASA 008740 59 ASA 008741 60 ASA 008742 61 ASA 008743 62 ASA 008744 63 ASA 008745 64 ASA 008746 65 ASA 008747 66 ASA 008748 67 ASA 008749 68 ASA 008750 69 ASA 008751 70 ASA 008752 71 ASA 008753 72 ASA 008754 73 ASA 008755 74 ASA 008756 75 ASA 008757 76 ASA 008758 77 ASA 008759 78 ASA 008760 79 ASA 008761 80 ASA 008762 81 ASA 008763 82 ASA 008764 83 ASA 008765 84 ASA 008766 85 ASA 008767 86 ASA 008768 87 ASA 008769 88 ASA 008770 89 ASA 008771 90 ASA 008772 91 ASA 008773 92 ASA 008774 93 ASA 008775 94 ASA 008776 95 ASA 008777 96 ASA 008778 97 ASA 008779 98 ASA 008780 99 ASA 008781 100 ASA 008782 101 ASA 008783 102 ASA 008784 103 ASA 008785 104 ASA 008786 105 ASA 008787 106 ASA 008788 107 ASA 008789 108 ASA 008790 109 ASA 008791 110 ASA 008792 111 ASA 008793 112 ASA 008794 113 ASA 008795 114 ASA 008796 115 ASA 008797 116 ASA 008798 117 ASA 008799 118 ASA 008800 119 ASA 008801 120 ASA 008802 121 ASA 008803 122 ASA 008804 123 ASA 008805 124 ASA 008806 125 ASA 008807 126 ASA 008808 127 ASA 008809 128 ASA 008810 129 ASA 008811 130 ASA 008812 131 ASA 008813 132 ASA 008814 133 ASA 008815 134 ASA 008816 135 ASA 008817 136 ASA 008818 137 ASA 008819 138 ASA 008820 139 ASA 008821 140 ASA 008822 141 ASA 008823 142 ASA 008824 143 ASA 008825 144 ASA 008826 - While in principle any number of codes can be generated, the greatest utility is achieved by minimizing the size of the encoding unit, which will likewise minimize the chemical investment in it.
- The disclosure of the following references is incorporated in their entirety herein by reference: Atherton, E. and Sheppard, R. C. (1989)Solid Phase Peptide Synthesis: A Practical Approach. IRL Press, Oxford. Bodanszky, A. and Bodanszky, M. (1984) The Practice of Peptide Synthesis. Springer-Verlag, Berlin.
-
-
- The R1 moiety is encoded by the C12 to C13 ratio sample, the R3 is encoded by the pool number from R3 was taken, and the R2 moiety is encoded by subtraction of the known R1 and R3 masses from the total construct mass.
-
-
-
-
-
-
-
-
-
- In a 200 ml recovery flask was placed 10.0 g of Fmoc-Cl, which was disolved in 100 ml of 80% dimethoxyethane. To this mixture was added approx. 35 ml of 10%15N-ammonia in water. A white precipitate began to form. The pH of the mixture was brought to 7-9. The reaction was allowed to proceed for 30 min.
- The reaction was acidified with 12N HCl and the white solid was filtered off and air dried. Further drying under vacuum gave a first crop yield of 8.072 g pure Fmoc-15NH2 as a white crystaline solid.
-
-
-
-
-
-
- Percentage/ratio solutions of14N/15N-photolinker were generated in the following manner (from 10.5 ml stock solutions DMF of each photolinker).
- 0%=20×0.050 ml of 10.5 ml14N-photolinker, and 0×0.050 ml of 10.5 ml 15N-photo
- 5%=19×0.050 ml of 10.5 ml14N-photolinker, and 1×0.050 ml of 10.5 ml 15N-photo
- 10%=18×0.050 ml of 10.5 ml14N-photolinker, and 2×0.050 ml of 10.5 ml 15N-photo
- 15%=17×0.050 ml of 10.5 ml14N-photolinker, and 3×0.050 ml of 10.5 ml 15N-photo
- 20%=16×0.050 ml of 10.5 ml14N-photolinker, and 4×0.050 ml of 10.5 ml 15N-photo
- 25%=15×0.050 ml of 10.5 ml14N-photolinker, and 5×0.050 ml of 10.5 ml 15N-photo
- 30%=14×0.050 ml of 10.5 ml14N-photolinker, and 6×0.050 ml of 10.5 ml 15N-photo
- 35%=13×0.050 ml of 10.5 ml14N-photolinker, and 7×0.050 ml of 10.5 ml 15N-photo
- 40%=12×0.050 ml of 10.5 ml14N-photolinker, and 8×0.050 ml of 10.5 ml 15N-photo
- 45%=11×0.050 ml of 10.5 ml14N-photolinker, and 9×0.050 ml of 10.5 ml 15N-photo
- 50%=10×0.050 ml of 10.5 ml14N-photolinker, and 10×0.050 ml of 10.5 ml 15N-photo
- 55%=9×0.050 ml of 10.5 ml14N-photolinker, and 11×0.050 ml of 10.5 ml 15N-photo
- 60%=8×0.050 ml of 10.5 ml14N-photolinker, and 12×0.050 ml of 10.5 ml 15N-photo
- 65%=7×0.050 ml of 10.5 ml14N-photolinker, and 13×0.050 ml of 10.5 ml 15N-photo
- 70%=6×0.050 ml of 10.5 ml14N-photolinker, and 14×0.050 ml of 10.,5 ml 15N-photo
- 75%=5×0.050 ml of 10.5 ml14N-photolinker, and 15×0.050 ml of 10.5 ml 15N-photo
- 80%=4×0.050 ml of 10.5 ml14N-photolinker, and 16×0.050 ml of 10.5 ml 15N-photo
- 85%=3×0.050 ml of 10.5 ml14N-photolinker, and 17×0.050 ml of 10.5 ml 15N-photo
- 90%=2×0.050 ml of 10.5 ml14N-photolinker, and 18×0.050 ml of 10.5 ml 15N-photo
- 95%=1×0.050 ml of 10.5 ml14N-photolinker, and 19×0.050 ml of 10.5 ml 15N-photo
-
- Starting with 6.3 g of aminomethyl polystyrene (0.21 mmol/g), divided into 21 equal lots of 0.300 grams each, were added the 1.0 ml solutions of varying ratios of15N-2 and 14N-2, in 5% increments (0%, 5%, 10%, to 100% 15N-2 photolinker) (see CDW FIG. 1). These solutions were generated by disolving 0.4988 g 14N-2 photolinker and 0.500 g 15N-2 photolinker, and using 0.050 ml aloquats of each (20:0, 19:1, 18:2, to 0:20). To the mixture was then added 0.169 ml diisopropylcarbodiimide. The samples were then mixed and the coupling ran overnight (approx. 16 hours). The resins were washed 8 times with 1.5 ml DMF, and then with copious amounts of methanol.
- Approx. 0.1 g of each lot was combined into 7 lots consisting of the following ratios per lot (see CDW FIG. 2). These 7 resin lots were used in the Tertiary Amine Library Study.
-
- Approx. 0.1 g of each resin lot ratio was coupled with 0.50 ml of a 10.5 ml, 0.55 g 15N-Fmoc-Alanine-OH in DMF solution, followed by the addition of 0.169 ml DIC. The coupling then ran overnight. The resins were washed with copious amounts of methanol and dried under vacuum (niinhydrin negative).
- A small amount of each resin lot, approx 0.01 g, was photo-cleaved for 4 hrs in 0.200 ml 3:1 water/THF. MS was subsequently performed.
-
-
-
-
-
- N-Fmoc-L-glycine.
- 1 g of each isotope labeled glycine (13.3 mmol) were dissolved in 15 mL of purified water and 1.4 g of sodium carbonate (see FIG. GP1). 15 mL of 1,4-Dioxane was added slowly to each and stirred. Over the period of two hours, 4.5 g of Fmoc-OSu (9-Fluorenylmethyl-N-hydroxysuccinimide) was added to each (see FIG. GP3 for scheme). Additional saturated sodium carbonate in water was added to maintain a pH=10. Solutions were allowed to stir overnight. 6M HCl was slowly added to the solution until the pH was approximately 2. Extraction of the compound was completed using 50 mL of ethyl acetate, washing four times with 50 mL of acidified/purified water. Aqueous portions were washed with 50 mL of ethyl acetate. Both portions of ethyl acetate were combined. Magnesium sulfate was added to remove any excess water. Samples were filtered and concentrated using a Roto Vap until the final volume was approximately one-third the original volume. Crystallization was completed using Hexane. Hexane was decanted and compound allowed to dry.
- N-Fmoc-L-alanine
- 1 g of each isotope labeled alanine (11.2 mmol) were dissolved in 15 mL of purified water and 1.2 g of sodium carbonate (see FIG. GP2). 15 mL of 1,4-Dioxane was added slowly to each and stirred. Over the period of two and a half hours, 3.8 g of Fmoc-OSu (9-Fluorenylmethyl-N-hydroxysuccinimide) was added to each (see FIG. GP3 for scheme). Additional saturated sodium carbonate in water was added to maintain a pH=10. Solutions were allowed to stir overnight. 6M HCl was slowly added to the solution until the pH was approximately 2. Extraction of the compound was completed using two
times 150 mL of ethyl acetate, washing four times with 300 mL of acidified/purified water. Magnesium sulfate was added to remove any excess water. Samples were filtered and concentrated using a Roto Vap until the final volume was approximately one-third the original volume. Crystallization was completed using Hexane. Hexane was decanted and compound allowed to dry. - The disclosure of the following references is incorporated in their entirety herein by reference: Atherton, E. and Sheppard, R. C. (1989)Solid Phase Peptide Synthesis: A Practical Approach. IRL Press, Oxford. Bodanszky, A. and Bodanszky, M. (1984) The Practice of Peptide Synthesis. Springer-Verlag, Berlin.
- Fmoc-protected alanine, serine and lysine were purchased from Bachem Bioscience. Fmoc-glycine was purchased from Novabiochem. Isotopically labeled amino acids were purchased from Cambridge Isotope Laboratories and were Fmoc protected in house (GP). Fmoc Knorr linker was purchased from Novabiochem. Fmoc-3-(2-nitrophenyl)-3-aminopropionic acid (a photolabile linkage agent) was purchased from Universal Organics. Aminomethyl polystyrene resin (0.81 mmol/gram) was purchased from Advanced ChemTech.
- Linkers were attached to solid support manually in reaction shakers (CM). Resin was split, to 85 reaction vessels on an Advanced ChemTech ACT496 MBS. Resin was deprotected with 25% piperidine/dimethylformamide twice for 10 minutes, then washed thoroughly with dimethylformamide. The first amino acids were coupled as 0.142 M solutions in N-methyl-pyrolidone, with PyBOP/Diisopropylethylamine in situ activation for 1.5 hours at room temperature. Boc deprotection was performed with 25 % trifluoroacetic acid in dichloromethane for 30 minutes. Acetylations were performed with 33 % acetic anhydride in dimethyl formamide for 30 minutes. All couplings were verified by ninhydrin color tests. Cleavage from the knorr linker was accomplished in 90% trifluoroacetic acid, 3% each water, phenol and thioanisole for 1.5 hours. Samples were dried under a nitrogen stream, then dissolved in water and lyophilized twice. Photocleavage was performed in 2:1 water:tetrahydrofuran under uv lamp for 12 hours. Samples were lyophiliized once.
- This array was designed to produce 20 samples with singlet, unique molecular weights for positive identification by mass spectroscopy. The samples were assembled in duplicate, one set of twenty on a chemically cleavable solid support, and the second set of twenty on a photocleavable support. By using a combination of one or two amino acids, a “coding region” was generated before addition of the synthetic ligand (in this case
- Acetyl-lysine). The twenty codes were constructed from the following amino acids:
- Glycine
- Glycine (15N)
- Glycine (2,2-D2)
- Alanine
- Alanine (15N)
- Alanine (1-13C)
- Serine
- After the coding region had been assembled, lysine was coupled as a test ligand as well as to generate a free amino side chain for ease of observation by mass spectroscopy. The a-amino group of the lysine was then acetylated.
- The codes and ligand were assembled on polystyrene resin functionalized with either Fmoc-Knorr or Fmoc-3-(2-nitrophenyl)-3-aminopropionic acid linkers.
- The array for the-single peak positional code is shown below:
FIG. 1 Position Position Position Total 1 2 3 MW 1 Ac- X X 187 Lys- 2 Ac- X -Gly0- 244 Lys- 3 Ac- X -Gly1- 245 Lys- 4 Ac- X -Gly2- 246 Lys- 5 Ac- X -Ala0- 258 Lys- 6 Ac- X -Ala1- 259 Lys- 7 Ac- X -Ala4- 262 Lys 8 Ac- X -Ser- 274 Lys- 9 Ac- -Gly0- -Gly0- 301 Lys- 1 Ac- -Gly0- -Gly1- 302 0 Lys- 1 Ac- -Gly1- -Gly1- 303 1 Lys- 1 Ac- -Gly2- -Gly1- 304 2 Lys- 1 Ac- -Gly2- -Gly2- 305 3 Lys- 1 Ac- -Ala0- -Gly0- 315 4 Lys- 1 Ac- -Ala1- -Gly0- 316 5 Lys- 1 Ac- -Ala0- -Gly2- 317 6 Lys- 1 Ac- -Ala1- -Gly2- 318 7 Lys- 1 Ac- -Ala4- -Gly2- 321 8 Lys- 1 Ac- -Ser- -Gly0- 331 9 Lys- 2 Ac- -Ser- -Gly1- 332 0 Lys - This array was designed to produce 20 samples with doublet peaks by mass spectroscopy; one peak arising from the ligand attached to a unique code, with a second peak resulting from a simultaneously assembled reference peak (ligand plus a fixed residue). As described in the SPPC above, by using a combination of one and two amino acids, a “coding region” was generated before addition of the synthetic ligand (in this case Acetyl-lysine). The twenty codes were also constructed from the following amino acids:
- Glycine
- Glycine (15N)
- Glycine (2,2-D2)
- Alanine
- Alanine (15N)
- Alanine (1-13C)
- Serine
- The codes and ligand were assembled on polystyrene resin functionalized with Fmoc-Knorr of Fmoc-3-(2-nitrophenyl)-3-aminopropionic acid linkers.
- The array for the double peak positional code is shown below:
FIG. 2 Position Position Position 1 2 3 Mwt 1 Ac- X X 187 Lys- 2 Ac- X -Gly0- 244 Lys- 3 Ac- X -Gly1- 245 Lys- 4 Ac- X -Gly2- 246 Lys- 5 Ac- X -Ala0- 258 Lys- 6 Ac- X -Ala1- 259 Lys- 7 Ac- X -Ala4- 262 Lys- 8 Ac- X -Ser- 274 Lys- 9 Ac- -Gly0- -Gly0- 301 Lys- 1 Ac- -Gly0- -Gly1- 302 0 Lys- 1 Ac- -Gly1- -Gly1- 303 1 Lys 1 Ac- -Gly2- -Gly1- 304 2 Lys- 1 Ac- -Gly2- -Gly2- 305 3 Lys- 1 Ac- -Ala0- -Gly0- 315 4 Lys- 1 Ac- -Ala1- -Gly0- 316 5 Lys- 1 Ac- -Ala0- -Gly2- 317 6 Lys- 1 Ac- -Ala1- -Gly2- 318 7 Lys- 1 Ac- -Ala4- -Gly2- 321 8 Lys- 1 Ac- -Ser- -Gly0- 331 9 Lys- 2 Ac- -Ser- -Gly1- 332 0 Lys- - In each of the samples produced in this experiment, the peptide molecular weight shown above will appear superimposed with the reference peak generated by Ac-Lys-Gly-NH2. This is to demonstrate the ability to identify both the first pooling lot and the molecular ion generated by the unknown ligand.
- To produce samples displaying the coded double peak, an orthogonal protection scheme was used. The first Fmoc-protected amino acid of the coding region was coupled simultaneously with an equimolar amount of Boc-glycine. The coding region was assembled using Fmoc chemistry, then the Boc protecting group was removed with trifluoroacetic acid. After a final removal of the code Fmoc protecting group with piperidine (which concommittentley neutralized TFA salts on the exposed amine of glycine), the ligand (acetyl llysine) was coupled. Upon photocleavage, two compounds were liberated in equimolar amounts : the ligand linked to a reference amino acid (glycine) and the ligand linked to a unique code. The mass difference between the two peaks indicates the identity of the code, and hence the identity of the first monomer of the ligand coupled.
- This array will produce twenty five samples, each dislying a unique molecular ion or peak pattern by mass spectroscopy. By using only combinations of isotopically labeled glycine at only two positions, twenty five unique “barcodes” are produced. In this manner the first pooled lot of any single bead derived from a split-combine library can be readily identified.
- In this experiment Fmoc-protected amino acids were coupled either as discretes or equimolar mixtures of two or three amino acids.
- The array for the mass spectral barcode is shown below:
FIG. 3 Peak Position 1 Position 2 Position 3 Pattern 1 Ac- -G0- -G0- 1 Lys- 2 Ac- -G1- -G0- 1 Lys- 3 Ac- -G0/G1- -G0- 1:1 Lys- 4 Ac- -G2- -G0- 1 Lys- 5 Ac- -G0/G2- -G0- 1:1 Lys- 6 Ac- -G1/G2- -G0- 1:1 Lys- 7 Ac- — -G0- 1:1:1 Lys- G0/G1/G2- 8 Ac- -G2- -G1- 1 Lys- 9 Ac- -G0/G2- -G1- 1:1 Lys- 1 Ac- -G0/G1- -G2- 1:1 0 Lys- 1 Ac- — -G1- 1:1:1 1 Lys- G0/G1/G2- 1 Ac- -G0/G1- -G0/G1- 1:2:1 2 Lys- 1 Ac- -G0/G2- -G0/G1- 1:1:1 3 Lys 1 Ac- -G1/G2- -G0/G1- 1:2:1 4 Lys- 1 Ac- — -G0/G1- 1:2:2:1 5 Lys- G0/G1/G2- 1 Ac- -G2- -G2- 1 6 Lys- 1 Ac- -G0/G2- -G2- 1:1 7 Lys- 1 Ac- -G0/G2- -G0/G2- 1:2:1 8 Lys- 1 Ac- -G1/G2- -G2- 1:1 9 Lys- 2 Ac- — -G2- 1:1:1 0 Lys- G0/G1/G2- 2 Ac- -G1/G2- -G0/G2- 1:1:1:1 1 Lys- 2 Ac- — -G0/G2- 1:1:2:1:1 2 Lys- G0/G1/G2- 2 Ac- -G1/G2- -G1/G2- 1:2:1 3 Lys- 2 Ac- — -G1/G2- 1:2:2:1 4 Lys- G0/G1/G2- 2 Ac- — — 1:2:3:2:1 5 Lys- G0/G1/G2- G0/G1/G2- - 4 g of aminomethylated polystyrene (0.81 mmol/g) was put into each of 2-250 mL shakers. The resin was swelled with dimethylformamide (DMF) and drained. The resin was then washed with 20% piperidine/DMF for ˜3 minutes and drained. The resin was washed three times with DMF, once with dichloromethane (DCM):DMF 1:1, and twice more with DMF.
- To the first shaker was added 3.5 equivalents of Knorr linker (6.12 g, 11.34 mmol) and 3.5 equivalents of PyBop (5.9 g, 11.34 mmol). Enough DMF was added to cover the resin bed. The solution was then activated with 10.5 equivalents of DIEA (5.93 mL, 34.02 mmol). The reaction ran for 1 hour with manual shaking every 5-10 min.
- To the second shaker was added 3.5 equivalents of photo linker (4.89 g, 11.34 mmol) and 3.5 equivalents of PyBop (5.9 g, 11.34 mmol). Enough DMF was added to cover the resin bed. The solution was then activated with 10.5 equivalents of DIEA (5.93 mL, 34.02 mmol). The reaction ran for 1 hour with manual shaking every 5-10 min.
- After 1 hour both shakers were drained. Ninhydrin tests indicated complete coupling for both linkers. The resin was washed four times with DMF, once with dichloromethane (DCM):DMF 1:1, and two more times with DMF.
- The resin was split to a 96 well ACT 496 Teflon reaction block.
-
- The seven lots of resin (CDW FIG. 2) were transferred to 10 mL shakers using dimethylfomniamide (DMF). The shakers were then covered with aluminum foil. The linker was Fmoc deprotected twice for 5 minutes each using 20% piperidine/DMF. The resin was washed four times with DMF, once with dichloromethane (DCM):DMF 1:1, and twice with DMF.
- 0.315 mmol of each of seven halo acids were weighed in separate vials and an equimolar amount of PyBop was added to each. The halo acids were then dissolved in 2 mL of DMF. Each solution was then added to the respective lot of resin and activated with 165 μL of diisopropylethylamine (DIEA). The coupling ran for 1 hour. After coupling the resins were drained and washed four times with DMF, once with DCM:DMF 1:1, and twice with DCM to dry the resin.
- 0.315 mmol of each of seven halo acids were weighed in separate vials and an equimolar amount of HBTU was added to each. The halo acids were then dissolved in 2 mL of DMF. Each solution was then added to the respective lot of resin and activated with 165 μL of DIEA. The coupling ran for 1 hour. After coupling the resins were drained and washed four times with DMF, once with DCM:DMF 1:1, and twice with DMF. Coupling was complete by ninhydrin.
- The resin lots were combined and split to 24 wells of a 96 well ACT 396 polypropylene reaction block. The resin was washed twice with DCM and dried.
- The resin was swelled with DMF and drained. 1 mL of 1.0 M amine solution in dimethylsulfoxide (DMSO) was added to each well. The reaction ran overnight. The resin was drained and washed twice with DMF, once with DMF:methanol:water (1:1:1), and washed three more times with DMF. The 24 lots of resin were then combined and split back to 24 wells.
- 350 μL of aldehyde solution (3.0 M/DMF) was added to each well and mixed for 2 minutes. An additional 250 μL of trimethylorthoformate was added to each well and mixed for 1 minute followed by 100 μL of 3% acetic acid in DMF. The reaction mixed for 15 minutes before a final addition of 1 mL of 1.5 M NaBH3CN. The reductive amination reaction ran for 3 hours. The resin was drained and washed twice with DMF.
- A second reductive amination was run using sodium triacetoxyborohydride. 350 μL of aldehyde solution (3.0 M/MMF) was added to each well and mixed for 2 minutes. An additional 250 μL of trimethylorthoformate was added to each well and mixed for 1 minute followed by 100 μL of 3% acetic acid in DMF. The reaction mixed for 15 minutes before a final addition of 1 mL of 1.5 M NaBH(O2CCH3). The reaction ran overnight. The resin was drained and washed twice with DMF, three times with DMF:methanol:water, three times with DCM, and three final times with methanol.
-
-
- The reaction screening is performed on the ligand portion of the molecule where 3 different monomers were used for the coupling of primary amines to allylic bromides as well as 4 different reaction conditions to give a total of 12 combinations. The acylation of secondary amines with carboxylic acids involved 4 different acids and 4 different reaction conditions to give another 16 combinations. The resin was pooled and treated with 36 different conditions for the final intramolecular Heck reaction to give over 6900 potential compounds that contains different monomers and reaction conditions. Upon single bead cleavage with TFA/MeCl2 and 6% triethylene both the encoded portion and the ligand are liberated as outlined above. The ligand is also encoded by the incorporation of glycine(0) and glycine(2) to help identify the ligand peaks in the mass spectrum.
- The mass spectra that are shown in FIGS. 10 through 12 contain both the code (544-562) and the ligand (462 and 464), (504 and 506), (478 and 480). The monomers and conditions that were run for that particular mass spectrum are listed on the spectrum.
- From these results one can use the combinatorial approach to look at various reaction conditions and monomers on a single bead and read both the code and the ligand when the material is cleaved off of the bead.
-
- 16 resin samples were synthesized where R was defined by a simultaneous coupling of
monomers 1 through 3 in different ratio patterns (ratios noted below). These resing could then be analysed by several analytical techniques to elucidate their ratio identity. The beads were analysed by IR, mass spec, NMR, and Amino Acid analysis. The ratios generated for the simultaneous coupling are defined R1:R2:R3 and were as follows for the 16 samples: #1-1:1:5; Sample #2-1:2:5; Sample #3-1:3:5; Sample #4-1:4:5; Sample #5-2:1:5; Sample #6-2:2:5; Sample #7-2:3:5; Sample #8-2:4:5; Sample #9-3:1:5; Sample #10-3:2:5; Sample #11-3:3:5; Sample #12-3:4:5-Sample #13-4:1:5; Sample #14-4:2:5; Sample #15-4:3:5; Sample #16-4:4:5. Spectra for these ratios is shown in the accompanying FIGS. 18 through 51 as follows:Sample IR Spectra Number Mass Spec. Number 1 u7125-86-1 CW-001 2 u7125-86-2 CW-002 3 u7125-86-3 CW-003 4 u7125-86-4 CW-004 5 u7125-86-5 CW-005 6 u7125-86-6 CW-006 7 u7125-86-7 CW-007 8 u7125-86-8 CW-008 9 u7125-86-9 CW-009 10 u7125-86-10 CW-0010 11 u7125-86-11 CW-0011 12 u7125-86-12 CW-0012 13 u7125-86-13 CW-0013 14 u7125-86-14 CW-0014 15 u7125-86-15 CW-0015 16 u7125-86-16 CW-0016 - The beads themselves generally used as solid supports in solid state synthesis can be isotopically doped. Styrene beads comprised of styrene can readily by doped with C13, F20 or H2. Additionally, it is possible to combine isotopically doped constructs with beads that have themselves been coded or tagged with one or more of a series of monomers.
- Styrene (Ms), 2-Fluorostyrene (M1), 3-Fluorosytrene, (M2) and 4-Fluorostyrene (M3) were deinhibited prior to polymerization by passing through an alumina adsorption column.
- The
initiator 2,2-azobisisobutyronitrile (AIBN) was purified by crystallization from methanol Specral grade toluene was used as solvent in a free radical polymerization without further purification.Run M1(%) M2(%) M3(%) Ms(%) YL4001 100 0 0 0 YL4002 0 100 0 0 YL4003 0 0 100 0 YL4004 0 0 0 100 YL4005 0 0 50 50 YL4006 0 10 40 50 YL4007 0 20 30 50 YL4008 0 20 30 50 YL4009 0 40 10 50 YL4010 0 50 0 50 YL4011 50 0 0 50 YL4012 40 10 0 50 YL4013 30 20 0 sO YL4014 20 30 0 50 YL4015 10 40 0 50 YL4016 40 0 10 50 YL4017 30 0 20 50 YL4018 20 0 30 50 YL4019 10 0 40 50 -
-
- A 1000 component library consisting of three monomer positions was designed to demonstrate the utility of the encoding strategy. The library was synthesized using the split-mix methodology to create a 10×10×10 library. Since the split mix method yields one compound per bead and the beads are mixed twice during the synthesis, the chemistry or monomer addition at each step must be recorded on the bead in order to decode the compound.
- The first position is encoded by controlling the ratio of12C:13C2 incorporated with bromoacetic acid in the first synthetic step. Ten unique ratios were employed with nine percent increments ranging from 9:91 to 90:10. The use of nine percent increments avoided the endpoints of either 0:100 or 100:0 while allowing a total of ten codes. The third monomer was alreacy known because the library was not recombined after addition of the final monomer (only one monomer from set three was present in each pool.) This position was therefore pool or spatially encoded.
- The second position was encoded by the molecular weight of the compound. Since monomer one is known by the isotopic reaction and monomer three by the final pool, monomer two can be calculated using the molecular weight determined by the mass spectrometer. This imposes one constraint for any library: the monomers in the second position must have different molecular weights. The other monomers have no restrictions. For this test example, the final pools were composed of compounds having unique molecular weights in order to facilitate decoding.
- Twenty single beads from each of the 10 pools were individually cleaved. The compounds were then analyzed by mass spectrometry and identified by the isotope ratio and molecular weight of the analyzed peaks. The peak resulting from the protonated monoisotopic ion was designated MOH+ while that resulting from the diisotopic ion (M0H+2)+ was designated M2H+. The deliberate doping with 13C2 controlled the intensity of the M2H+ peak relative to the M0H+ peak.
- Mass spectral data from a single bead in
pool 3 showed that M0H+ and M2H+ were 552 and 554, respectively. The M0H+:M2H+ ratio was calculated to be 10:90, which was quite close to the actual ratio for ion 552, which was 9:91. Using M0H+ as 550 and M2H+ as 552, the calculated M0H+ to M2H+ ratio was 56:44. The compound having a M0H+ ion inpool 2 had a theoretical of 54:46, again in very close agreement to the calculated ratio. In some cases, side-reactions involved in the addition of monomers may complicate the spectra. Spectra 2C below shows the mass spectrum of a single bead frompool 1. The most intense ion in the spectrum is at m/z 586. However, the calculated M0H+:M2H+ ratio (65:35) does no agree with known ration for the compound inpool 1 with M0H+ of 586. This apparent discrepancy is due to the addition of the third monomer forpool 1, a nitrile. It is known that under acidic conditions (cleavage conditions) nitriles can be hydrated to an amide. With the addition of water, the peaks for the M0H+ ion at 586 shift to 586 (M0H+18). Thus, the M0H30 :M2H+ ratio for the peaks at 586 and 588 verifies the encode for the ion at 568 (which has its own, weaker set of peaks having the same ratio.). The known ration for the compound inpool 1 with a M0H+ ion of 568 is 63:37, which corresponds to the calculated value. This particular hydration reaction was observed for all compounds inpool 1. This example demonstrates the ability to decode compounds and determine side reactions, a powerful enhancement over other encoding methodologies which would be very useful during solid phase chemistry development. - 1. Input the molecular formula and isotope ratios of an encoded compound.
- 2. Calculate the monoisotopic molecular weight from
step 1. - 3. Calculate the theoretical isotope distribution from
step 1. - 4. Open the mass spectrum output file.
- 5. Locate the monoisotopic molecular weight in the mass spectrum output file to within +/− 0.3 amu and check for corresponding isotope peaks.
- 6. If
step 5 was successful compare the theoretical distribution fromstep 3 with the measured values in the mass spectrum using a Chi-Square test. The outcome of the Chi-Square determines the presence or absence of the encoded compound. -
Copyright 1996, Glaxo Wellcome, Inc. All rights reserved. - This invention is executable on a MacIntosh computer or a IBM-PC compatible computer, running the
Windows 95, Windows NT or Macintosh OS operating system, which includes a CPU, main storage, I/O resources, and a user interface including a manually operated keyboard and mouse. - While the invention has been described and illustrated with reference to certain alternative embodiments thereof, those skilled in the art will appreciate that various changes, modifications and substitutions can be made therein without departing from the spirit and scope of the invention. It is intended, therefore, that the invention be limited only by the scope of the claims which follow, and that such claims be interpreted as broadly as possible.
Claims (78)
1. A mass-based, non-chemical method for recording the reaction of at least a portion of a reaction series on each of a plurality of unique solid supports, said method comprising:
(a) preparing a plurality of agents each having a unique defined mass;
(b) preparing a group of solid supports;
(c) reacting each solid support group with a different chemical reagent under a controlled reaction condition;
(d) mixing the product groups of step (c) together and then dividing said mixture of unique solid supports into a plurality of groups for a second intermediate or final stage;
(e) repeating said reacting with a chemical reagent under a controlled reaction condition at least once to provide a plurality of final products, having different products on the different individual unique solid supports;
each of said unique defined mass agents being reacted with either: each of a group of unique solid supports; each of a group of first chemical reagents in a reaction series; each of a group of second chemical reagents in a reaction series; or each of a group of subsequently added chemical reagents in a reaction series; such that each of said group of unique solid supports, group of first chemical reagents, group of second chemical reagents or group of subsequent chemical reagents has been reacted with an agent having a defined mass that is different from any other defined mass agent reacted with any other of said groups;
said unique defined mass agents being capable of being analyzed and wherein said analysis defines the choice of a first chemical reagent, reaction condition under which said first chemical reagent was added, second chemical reagent, reaction condition under which said second chemical reagent was added, subsequent chemical reagent, or reaction condition under which said subsequent chemical reagent was added.
2. A mass-based, non-chemical method for recording the reaction history of a reaction series on each of a plurality of unique solid supports, said method comprising:
(a) reacting, at a mass block insertion stage, a plurality of agents each having a unique defined mass with each of a group of said unique solid supports, such that each of said group of unique solid supports has been reacted with an agent having a defined mass that is different from any other agent reacted with any other of said groups of said unique solid supports;
(b) reacting each solid support group having a different defined mass agent with a different chemical reagent;
(c) mixing said groups together and then dividing said plurality of unique solid supports into a plurality of groups for a second intermediate or final stage;
(d) repeating said reacting with a chemical reagent at least once to provide a plurality of final products, having different products on the different individual unique solid supports;
said unique defined mass agents being capable of being analyzed and wherein said analysis defines the choice of a first chemical reagent.
3. The method as claimed in claim 1 , wherein said defined mass agents are analyzed by mass spectroscopy.
4. The method as claimed in claim 3 , wherein said defined mass agents are selected so as to each generate a unique single mass peak when analyzed by mass spectroscopy.
5. The method as claimed in claim 3 , wherein said defined mass agents are selected so as to each generate a unique double mass peak when analyzed by mass spectroscopy.
6. The method as claimed in claim 3 , wherein said defined mass agents are selected so as to each generate a unique pair of single mass peaks when analyzed by mass spectroscopy.
7. The method as claimed in claim 3 , wherein said defined mass agents are selected so as to each generate a unique pair of double mass peaks when analyzed by mass spectroscopy.
8. The method as claimed in claim 3 , wherein said defined mass agents are selected so as to each generate a unique pattern of one or more mass peaks.
9. The method as claimed in claim 8 , wherein said unique peak patterns for each of said defined mass agents can be expressed as a machine-readable pattern.
10. The method as claimed in claim 9 , wherein said machine readable patterns are bar codes.
11. The method as claimed in claim 3 , wherein said defined mass agents are selected so as to each independantly generate a unique mass spectrometry mass peak pattern selected from the group consisting of unique single mass peaks, unique double mass peaks, unique pairs of single mass peaks, unique pairs of double mass peaks, and unique peak patterns that are capable of being expressed as machine-readable patterns.
12. The method as claimed in claim 1 , wherein said defined mass agent is analyzed by nuclear magnetic resonance spectroscopy.
13. The method as claimed in claim 12 , wherein said defined mass agents are selected so as to each generate a unique pattern of one or more nuclear magnetic resonance peaks.
14. The method as claimed in claim 13 , wherein said unique peak patterns for each of said defined mass agents can be expressed as a machine-readable pattern.
15. The method as claimed in claim 14 , wherein said machine readable patterns are bar codes.
16. The method as claimed in claim 1 , wherein said defined mass agent is analyzed by infrared spectroscopy or by Raman spectroscopy.
17. The method as claimed in claim 16 , wherein said defined mass agents are selected so as to each generate a unique pattern of one or more infrared spectroscopy or Raman spectroscopy peaks.
18. The method as claimed in claim 17 , wherein said unique peak patterns for each of said defined mass agents can be expressed as a machine-readable pattern.
19. The method as claimed in claim 18 , wherein said machine readable patterns are bar codes.
20. The method as claimed in claim 1 , wherein said first, second or subsequent reagent is a substrate for the determination of binding specificity to a chemical compound of interest.
21. The method as claimed in claim 3 , wherein said mass spectroscopy analysis provides mass peaks capable of being recognized as representing encoded reagents.
22. The method as claimed in claim 1 , wherein additional mass peaks are generated that serve as signature peaks for positive identification of relevant mass peaks.
23. The method as claimed in claim 1 , wherein said plurality of defined mass agents are molecular entities that differ from one another by having at least one of their atoms substituted by a different isotope of that atom, provided that the chemical structural formula of said defined mass agents is the same.
24. The method as claimed in claim 23 , wherein said plurality of defined mass agents are molecular entities that differ from one another by having at least one isotopic substitution at different atomic positions within the molecule provided that the chemical structural formula of said defined mass agents is the same.
25. The method as claimed in claim 1 , wherein said plurality of defined mass agents are regularly repeating molecular entities that differ from one another by an integral number of said repeating molecular entities.
26. The method as claimed in claim 1 , wherein at least two groups of said unique solid supports are employed in each said reacting.
27. The method as claimed in claim 1 , comprising the additional step of screening said final products on said unique solid supports for a characteristic of interest and identifying the reaction history of at least one final product having said characteristic of interest.
28. The method as claimed in claim 1 , comprising the additional step of cleaving said final products from said solid supports and screening said final products.
29. The method as claimed in claim 1 , wherein said analysis is automated.
30. The method as claimed in claim 10 , wherein said reaction steps are automated.
31. A kit for encoding the reaction history of a plurality of reaction series, comprising a plurality of different isotopically distinguishable organic compounds, each of the compounds characterized by having distinguishable masses but having the same chemical composition and the same chemical properties, each compound encoding at least one bit of different physical information which can be determined by a physical measurement.
32. A kit as claimed in claim 31 , wherein said compounds are mixed with one another in a plurality of discrete ratios to produce a plurality of isotope mixtures that are physically distinguishable from each other.
33. A kit as claimed in claim 32 , wherein said compounds are mixed with one another in a series of regularly repeating increasing increments.
34. A kit as claimed in claim 31 , wherein said compounds are of the formula:
R—C
where R is a suitable solid support which allows for attachment and detachment of a molecular moiety of choice; and C is an isotopically doped linker which allows for attachment and detachment from said solid supprt.
35. A kit as claimed in claim 31 , wherein said compounds are of the formula:
L1-C-L2
where L1 is a covalent bond or an organic moiety; C is an isotopically doped linker; and L2 is a covalent bond or an organic moiety.
36. A kit as claimed in claim 35 , wherein L1 and L2 are the same.
37. A kit as claimed in claim 31 , wherein said compounds are of the formula
R-L1-C-L2
where R is a suitable solid support which allows for attachment and detachment of a molecular moiety of choice; L1 is a covalent bond or an organic moiety; C is an isotopically doped linker; and L2 is a covalent bond or an organic moiety.
38. A kit as claimed in claim 31 , wherein said compounds are of the formula
(L)n1-(C)n2
where n1 is an integer of from one to ten, n2 is an integer of from one to ten, L an organic moiety or a covalent bond when n1 is one, and C is an isotopically doped linker.
39. A kit as claimed in claim 31 , wherein said compounds are of the formula
R-L-C
where R is a suitable solid support which allows for attachment and detachment of a plurality of molecular moiety of choice; L is a covalent bond or an organic moiety; and C is an isotopically doped linker.
40. A kit as claimed in claim 31 , wherein said compounds are of the formula
L-C1A-B-D-C2
L is a covalent bond or an organic moiety; C1 is an isotopically doped linker; A is a first monomer in a reaction series, B is a second monomer in a reaction series, and D is a third monomer in a reaction series; and C2 is a second isotopically doped linker that can physically be the same as or different from C1.
41. A kit as claimed in claim 31 , wherein said compounds are of the formula
L-C1-A-B-C2
L is a covalent bond or an organic moiety; C1 is an isotopically doped linker; A is a first monomer in a reaction series, B is a second monomer in a reaction series; and C2 is a second isotopically doped linker that can physically be the same as or different from C1.
42. A kit as claimed in claim 31 , wherein said compounds are of the formula
L-C1-A-C2
L is a covalent bond or an organic moiety; C1 is an isotopically doped linker; A is a first monomer in a reaction series; and C2 is a second isotopically doped linker that can physically be the same as or different from C1.
43. A kit as claimed in claim 31 , wherein said components are isotopically doped suitable solid supports.
46. A solid support characterized by having a unique defined mass agent and a ligand bound to the surface of said solid support.
47. A solid support characterized by having up to 20 discrete unique defined mass agents bound to the surface of said solid support.
48. A solid support as claimed in claim 46 , wherein said ligand is an organic moiety.
49. A solid support as claimed in claim 46 , wherein said ligand is bound to said unique defined mass agent.
50. A solid support as claimed in claim 46 , wherein said ligand is a non-oligomer which is aliphatic, alicyclic, aromatic, heterocyclic or a combination thereof.
51. A solid support as claimed in claim 46 , wherein said ligand is an oligomer which is an oligopeptide, oligonucleotide, oligosaccharide, polylipid, polyester, polyamide, polyurethane, polyurea, polyether, polyphosphorus where phosphorus is a derivative taken from the group consisting of phosphate, phosphonate, phosphoramide, phosphonamide, phosphite, or phosfinamide, or polysulfur where sulfur is a derivative taken from the group consisting of sulfone, sulfonate, sulfite, sulfinamiide, or sulfenamide.
52. A solid support as claimed in claim 46 , wherein said support is a resin bead of about 1 to 10000 μm in diameter.
53. A solid support as claimed in claim 46 , wherein said support is a polystyrene resin bead of about 1 to 10000 μm in diameter.
54. A solid support characterized by being isotopically doped.
55. A solid support as claimed in claim 54 , wherein said support is an isotopically doped resin bead.
56. A solid support as claimed in claim 55 , wherein said support is an isotopically doped polystyrene resin bead of about 10 to 2000 μm in diameter.
57. A library comprising a plurality of solid supports as claimed in claim 46 .
58. A library comprising a plurality of solid supports as claimed in claim 46 , wherein said final products have been cleaved from said solid supports.
59. A process for identifying compounds having a characteristic of interest, which comprises screening a library as claimed in claim 57 .
60. A process as claimed in claim 59 , wherein the compounds have been cleaved from the solid support.
61. A process as claimed in claim 60 , wherein said cleavage is between said solid support and said unique defined mass agent.
62. A mass-based, non-chemical method for generating machine or human-recognizable patterns to record the reaction history of a reaction series on each of a plurality of unique solid supports, said method comprising:
(a) generating a set of agents each having a unique defined mass such that each agent differs from any other agent in the set by having a defined mass that is different from any other agent in the set;
(b) generating a recognition pattern for each agent in said set;
(c) reacting, at a mass block insertion stage, a plurality of agents each having a unique defined mass with each of a group of said unique solid supports, such that each of said group of unique solid supports has been reacted with an agent having a defined mass that is different from any other agent reacted with any other of said groups of said unique solid supports;
(d) reacting each solid support group having a different defined mass agent with a different first chemical reagent;
(e) mixing said groups together and then dividing said plurality of unique solid supports into a plurality of groups for a second intermediate or final stage;
(f) optionally repeating said reacting with a chemical reagent at least once to provide a plurality of final products, having different products on the different individual unique solid supports;
(g) analyzing said products for a characteristic of interest,
(h) further analyzing products found to have a characteristic of interest in step (g) by an analytical method that generates a like type of patterns as that type generated for the recognition patterns in step (b); and
(i) comparing the analytical patterns generated in step (h) to said recognition patterns.
63. A mass-based, non-chemical method for generating machine-recognizable patterns to record the reaction history of a reaction series on each of a plurality of unique solid supports, said method comprising:
(a) generating a set of agents each having a unique defined mass such that each agent differs from any other agent in the set by having a defined mass that is different from any other agent in the set;
(b) generating a machine-recognizable recognition pattern for each agent in said set;
(c) reacting, at a mass block insertion stage, a plurality of agents each having a unique defined mass with each of a group of said unique solid supports, such that each of said group of unique solid supports has been reacted with an agent having a defined mass that is different from any other agent reacted with any other of said groups of said unique solid supports;
(d) reacting each solid support group having a different defined mass agent with a different first chemical reagent;
(e) mixing said groups together and then dividing said plurality of unique solid supports into a plurality of groups for a second intermediate or final stage;
(f) optionally repeating said reacting with a chemical reagent at least once to provide a plurality of final products, having different products on the different individual unique solid supports;
(g) analyzing said products for a characteristic of interest through the use of an analysis device;
(h) further analyzing products found to have a characteristic of interest in step (g) by an analytical method that generates a like type of patterns as that type generated for the recognition patterns in step (b); and
(i) comparing the analytical patterns generated in step (h) to said recognition patterns such that said unique defined mass agents are capable of being analyzed and identified.
64. The method as claimed in claim 63 , wherein said identification in step (i) leads to the -ready identification of said first chemical reagent.
65. The method as claimed in claim 63 , wherein said method steps are executed by suitable automation apparatus means and under the control of a suitable computer means.
66. The method as claimed in claim 63 , wherein said analysis device is selected from the group consisting of a flourescence activation cell scanner, a chromatography column or a chromatography plate.
67. The method as claimed in claim 63 , wherein said analytical method is selected from the group consisting of mass spectrometry, nuclear magnetic resonance spectroscopy, infrared spectroscopy or Raman spectroscopy.
68. The method as claimed in claim 63 wherein said analysis device is close coupled to said automation apparatus used in the method so as to be automated and under the control of a computer.
69. The method as claimed in claim 63 , wherein said analytical method is executed by a corresponding device that is close coupled to said automation apparatus used in the method so as to be automated and under the control of a computer.
70. A database readily retrievable from a suitable data storage means comprised of the set of machine-readable patterns generated by the method as claimed in claim 63 .
71. A mass-based, non-chemical method for generating machine or human-recognizable patterns to record the reaction history of a reaction sequence of interest selected from a reaction series on each of a plurality of unique solid supports, said method comprising:
(a) generating a set of agents each having a unique defined mass such that each agent differs from any other agent in the set by having a defined mass that is different from any other agent in the set;
(b) generating a recognition pattern for each agent in said set;
(c) reacting, at a mass block insertion stage, a plurality of agents each having a unique defined mass with each of a group of said unique solid supports, such that each of said group of unique solid supports has been reacted with an agent having a defined mass that is different from any other agent reacted with any other of said groups of said unique solid supports;
(d) reacting each solid support group having a different defined mass agent with a different first chemical reagent;
(e) mixing said groups together and then dividing said plurality of unique solid supports into a plurality of groups for a second intermediate or final stage;
(f) optionally repeating said reacting with a chemical reagent at least once to provide a plurality of final products, having different products on the different individual unique solid supports;
(g) analyzing said products for a characteristic of interest;
(h) further analyzing products found to have a characteristic of interest in step (g) by an analytical method that generates a like type of patterns as that type generated for the recognition patterns in step (b);
(i) comparing the analytical patterns generated in step (h) to said recognition patterns;
(j) evaluating said analytical patterns to arrive at a qualitative and quantitative assessment of the output of a reaction sequence of interest, thereby identifying all products, quantities and yields of each of incomplete reactions, side reactions and previously unknown reactions in said sequence of interest.
72. A mass-based, non-chemical method for recording the reaction history of a reaction series in solution, said method comprising:
(a) preparing, a plurality of agents each having a unique defined mass within each of a group of solution reaction wells, such that each of said group of reaction wells contains an agent having a defined mass that is different from any other agent within any other of said reaction wells;
(b) reacting each different defined mass agent with a different first chemical reagent in each well;
(c) mixing said groups together in to a resulting batch and then dividing said batch into a plurality of wells for a second intermediate or final stage;
(d) repeating said reacting with a chemical reagent at least once to provide a plurality of final products, having different products within said wells;
said unique defined mass agents being capable of being analyzed and wherein said analysis defines the choice of said first chemical reagent.
73. A programmed computer system for executing a mass-based method for recording the reaction history of at least a portion of a reaction series of interest on each of a plurality of solid supports or in each or a plurality of reaction vessels, wherein one or more chemical reagents or chemical conditions are discretely identifiable by one or more recognition patterns and wherein said reaction series chemical products are subjected to analytical means that generate analytical patterns for each of said products; comprising:
first input means for introducing unique recognition patterns into the computer system, each pattern representing one of a plurality of agents each having a unique defined mass;
memory means for storing said recognition pattern;
second input means for introducing said resultant analytical patterns; and
means for comparing said resulting analytical patterns to said recognition patterns in order to generate an output which is the identity of one or more of said chemical reagents or chemical conditions.
74. The programmed computer system as claimed in claim 73 , additionally comprising means for controlling a robot means for performing one or more steps of said reaction series of interest.
75. The programmed computer system as claimed in claim 73 , additionally comprising means for generating said unique recognition patterns.
76. The programmed computer system as claimed in claim 73 , additionally comprising means for subjecting said reaction products to analytical means and generating analytical patterns.
77. A mass-based, non-chemical method for identifying different chemical compounds in a mixture of said chemical compounds, said method comprising:
(a) preparing a plurality of chemical agents each having a unique defined mass;
(b) preparing a group of chemical compounds to be identified;
each of said unique defined mass agents being chemically linked or reacted with each of said chemical compounds to be identified to form a plurality of unique covalently bound one-to-one pairs of unique defined mass agents with compounds to be identified;
said unique defined mass agents being capable of being analyzed on the basis of its mass, and wherein said analysis thus identifies the chemical compound reacted with said analyzed mass agent.
78. A mass-based, non-chemical method for identifying a chemical compound, said method comprising:
(a) preparing a chemical agent having a unique defined mass;
(b) preparing a chemical compound to be identified;
said unique defined mass agent being chemically linked or reacted with said chemical compound to be identified to form a unique covalently bound one-to-one pairing of unique defined mass agent with compound to be identified;
said unique defined mass agent being capable of being analyzed on the basis of its mass, and wherein said analysis thus identifies the chemical compound reacted with said analyzed mass agent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/172,525 US20030100018A1 (en) | 1995-12-22 | 2002-08-06 | Mass-based encoding and qualitative analysis of combinatorial libraries |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US919295P | 1995-12-22 | 1995-12-22 | |
PCT/US1996/020766 WO1997023214A1 (en) | 1995-12-22 | 1996-12-20 | 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
US9159498A | 1998-06-18 | 1998-06-18 | |
US10/172,525 US20030100018A1 (en) | 1995-12-22 | 2002-08-06 | Mass-based encoding and qualitative analysis of combinatorial libraries |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US9159498A Division | 1995-12-22 | 1998-06-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
US20030100018A1 true US20030100018A1 (en) | 2003-05-29 |
Family
ID=21736135
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/091,594 Expired - Fee Related US6130234A (en) | 1995-12-22 | 1996-12-20 | 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists |
US09/592,883 Expired - Fee Related US6448270B1 (en) | 1995-12-22 | 2000-06-13 | 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists |
US10/206,578 Abandoned US20030105133A1 (en) | 1995-12-22 | 2002-07-29 | 4-Substituted piperidine analogs and their use as subtype selective NMDA receptor, antagonists |
US10/172,525 Abandoned US20030100018A1 (en) | 1995-12-22 | 2002-08-06 | Mass-based encoding and qualitative analysis of combinatorial libraries |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/091,594 Expired - Fee Related US6130234A (en) | 1995-12-22 | 1996-12-20 | 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists |
US09/592,883 Expired - Fee Related US6448270B1 (en) | 1995-12-22 | 2000-06-13 | 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists |
US10/206,578 Abandoned US20030105133A1 (en) | 1995-12-22 | 2002-07-29 | 4-Substituted piperidine analogs and their use as subtype selective NMDA receptor, antagonists |
Country Status (22)
Country | Link |
---|---|
US (4) | US6130234A (en) |
EP (1) | EP0869791B1 (en) |
JP (1) | JP2000502352A (en) |
AT (1) | ATE239473T1 (en) |
AU (1) | AU719430B2 (en) |
BG (1) | BG63424B1 (en) |
BR (1) | BR9612153A (en) |
CA (1) | CA2240038A1 (en) |
CZ (1) | CZ177898A3 (en) |
DE (1) | DE69628035T2 (en) |
DK (1) | DK0869791T3 (en) |
EA (1) | EA001133B1 (en) |
ES (1) | ES2196196T3 (en) |
IL (1) | IL125060A (en) |
MX (1) | MX9805032A (en) |
NO (1) | NO312028B1 (en) |
NZ (1) | NZ325735A (en) |
PL (1) | PL327413A1 (en) |
PT (1) | PT869791E (en) |
SK (1) | SK82398A3 (en) |
WO (1) | WO1997023214A1 (en) |
ZA (1) | ZA9610741B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030124595A1 (en) * | 2001-11-06 | 2003-07-03 | Lizardi Paul M. | Sensitive coded detection systems |
US20050069916A1 (en) * | 2000-08-11 | 2005-03-31 | Chait Brian T. | Ultra-sensitive detection systems |
US20070207555A1 (en) * | 2005-02-03 | 2007-09-06 | Cesar Guerra | Ultra-sensitive detection systems using multidimension signals |
US20160327543A1 (en) * | 2014-01-02 | 2016-11-10 | John P. Jasper | Method for continuously monitoring chemical or biological processes |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA9610736B (en) * | 1995-12-22 | 1997-06-27 | Warner Lambert Co | 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists |
AU4424697A (en) * | 1996-09-11 | 1998-04-02 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | The use of functional n-methyl-d-aspartate antagonists to ameliorate or prevent aminoglycoside-induced ototoxicity |
GB9704948D0 (en) * | 1997-03-11 | 1997-04-30 | Knoll Ag | Therapeutic agents |
IL134363A0 (en) | 1997-10-24 | 2001-04-30 | Warner Lambert Co | Method for treating disease-related or drug-induced dyskinesias |
US6960577B2 (en) * | 1998-05-22 | 2005-11-01 | Eli Lilly And Company | Combination therapy for treatment of refractory depression |
PE20000728A1 (en) * | 1998-06-26 | 2000-08-21 | Cocensys Inc | HETEROCYCLES 4-BENZYL PIPERIDINE ALKYLSULFOXIDE AND THEIR USE AS SUBTYPE-SELECTIVE NMDA RECEPTOR ANTAGONISTS |
US8722668B2 (en) * | 1998-12-23 | 2014-05-13 | Daryl W. Hochman | Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders |
US8008283B2 (en) * | 1998-12-23 | 2011-08-30 | Neurotherapeutics Pharma, Inc. | Methods and compositions for the treatment of neuropsychiatric disorders |
US20060025387A1 (en) * | 1998-12-23 | 2006-02-02 | Cytoscan Sciences Llc | Compositions and methods for the treatment of disorders of the central and peripheral nervous systems |
US7214711B2 (en) * | 1998-12-23 | 2007-05-08 | Neurotherapeutics Pharma Llc | Method of treating migraine headache without aura |
US6316474B1 (en) * | 1999-10-29 | 2001-11-13 | Merck & Co., Inc. | 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists |
EP1186303A3 (en) * | 2000-09-06 | 2003-12-10 | Pfizer Products Inc. | Pharmaceutical combinations, for the treatment of stroke and traumatic brain injury, containing a neutrophil inhibiting factor and an selective NMDA-NR2B receptor antagonist |
IL145584A0 (en) * | 2000-10-02 | 2002-06-30 | Pfizer Prod Inc | Nmda nr2b antagonists for treatment |
EP1674087A1 (en) | 2000-10-02 | 2006-06-28 | Pfizer Products Inc. | Prophylactic use of n-methyl-d-aspartate (NMDA) antagonists |
ZA200108038B (en) * | 2000-10-02 | 2003-04-01 | Pfizer Prod Inc | Prophylactic use of n-methyl-d-asparrate (NMDA) antagonists. |
CA2436699A1 (en) | 2000-12-21 | 2002-06-27 | Warner-Lambert Company Llc | Piperidine derivatives as subtype selective n-methyl-d-aspartate antagonists |
ES2312603T3 (en) | 2001-07-24 | 2009-03-01 | Richter Gedeon Nyrt | PIPERIDINE DERIVATIVES AS ANTAGONISTS OF THE NMDA RECEIVER. |
ES2266618T3 (en) * | 2001-08-23 | 2007-03-01 | Bayer Cropscience S.A. | SUBSTITUTED PROPARGILAMINS. |
JPWO2003035641A1 (en) * | 2001-10-22 | 2005-02-10 | 塩野義製薬株式会社 | New carbamoylpyrrolidone derivatives |
DE10201550A1 (en) * | 2002-01-17 | 2003-07-31 | Merck Patent Gmbh | Phenoxy piperidines |
WO2005037286A1 (en) | 2003-03-25 | 2005-04-28 | Vasopharm Biotech Gmbh | Use of pteridine derivatives for the treatment of increased intracranial pressure and secondary ischemia |
US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
WO2005051919A1 (en) * | 2003-11-26 | 2005-06-09 | Pfizer Products Inc. | Aminopyrazole derivatives as gsk-3 inhibitors |
CN102293774A (en) * | 2005-03-31 | 2011-12-28 | 旭硝子株式会社 | Application of prostaglandin f2 alpha derivative |
RU2392938C2 (en) * | 2005-04-13 | 2010-06-27 | Убе Индастриз, Лтд | Protective agent for neural retina cells containing indazole derivatives as active ingredient |
AU2006264043B2 (en) | 2005-06-28 | 2012-04-26 | Sanofi-Aventis | Isoquinoline derivatives as inhibitors of Rho-kinase |
RS52241B (en) | 2005-07-26 | 2012-10-31 | Sanofi | Cyclohexylamin isoquinolone derivatives as rho-kinase inhibitors |
CN101228149B (en) | 2005-07-26 | 2013-01-02 | 塞诺菲-安万特股份有限公司 | Piperidinyl-substituted isoquinolone derivatives as rho-kinase inhibitors |
JP2009511629A (en) * | 2005-10-17 | 2009-03-19 | ニューロセラピューティクス ファーマ, インコーポレイテッド | Analogues of diuretic-like compounds useful in the regulation of central nervous system diseases |
WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
SI2091948T1 (en) | 2006-11-30 | 2012-07-31 | Probiodrug Ag | Novel inhibitors of glutaminyl cyclase |
CA2673921C (en) | 2006-12-27 | 2015-10-20 | Sanofi-Aventis | New substituted isoquinoline and isoquinolinone derivatives |
CN101611012B (en) | 2006-12-27 | 2012-11-14 | 塞诺菲-安万特股份有限公司 | Cycloalkylamine substituted isoquinoline derivatives |
CA2673918C (en) | 2006-12-27 | 2015-02-17 | Sanofi-Aventis | Substituted isoquinoline and isoquinolinone derivatives |
NZ577980A (en) | 2006-12-27 | 2012-01-12 | Sanofi Aventis | Cycloalkylamine substituted isoquinolone derivatives |
AU2007338412B2 (en) | 2006-12-27 | 2013-03-14 | Sanofi-Aventis | Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives |
WO2008077550A1 (en) | 2006-12-27 | 2008-07-03 | Sanofi-Aventis | Substituted isoquinoline and isoquinolinone derivatives as inhibitors of rho-kinase |
EP2481408A3 (en) | 2007-03-01 | 2013-01-09 | Probiodrug AG | New use of glutaminyl cyclase inhibitors |
DK2142514T3 (en) | 2007-04-18 | 2015-03-23 | Probiodrug Ag | Thiourea derivatives as glutaminyl cyclase inhibitors |
PL2303846T3 (en) | 2008-06-24 | 2015-10-30 | Sanofi Sa | Substituted isoquinolines and isoquinolinones as rho kinase inhibitors |
NZ590067A (en) | 2008-06-24 | 2012-09-28 | Sanofi Aventis | Bi-and polycyclic substituted isoquinoline and isoquinolinone derivatives as rho kinase inhibitors |
DK2313374T3 (en) | 2008-06-24 | 2013-12-16 | Sanofi Sa | 6-SUBSTITUTED ISOQUINOLINES AND ISOQUINOLINONES |
AU2010294214B2 (en) | 2009-09-11 | 2015-05-07 | Vivoryon Therapeutics N.V. | Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
JP6026284B2 (en) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | Inhibitors of glutaminyl cyclase |
AU2011226074B2 (en) | 2010-03-10 | 2015-01-22 | Vivoryon Therapeutics N.V. | Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5) |
EP2560953B1 (en) | 2010-04-21 | 2016-01-06 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
JP6050264B2 (en) | 2011-03-16 | 2016-12-21 | プロビオドルグ エージー | Benzimidazole derivatives as inhibitors of glutaminyl cyclase |
US8772276B2 (en) * | 2011-05-03 | 2014-07-08 | Merck Sharp & Dohme Corp. | Alkyne benzotriazole derivatives |
US20140322315A1 (en) | 2011-11-22 | 2014-10-30 | The Regents Of The University Of California | Cysteamine and/or cystamine for treating ischemic injury |
US11066366B2 (en) | 2015-09-03 | 2021-07-20 | Allegheny-Singer Research Institute | Hydrophilic fentanyl derivatives |
SI25272A (en) * | 2016-09-23 | 2018-03-30 | Univerza V Ljubljani | Disubstituted azetidines, pyrrolidines, piperidines and azepanes as inhibitors of monoamine oxidase B for the treatment of neurodegenerative diseases |
PL3461819T3 (en) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
CN114409680B (en) * | 2018-01-19 | 2023-11-21 | 上海怡立舍生物技术有限公司 | PPAR agonists and uses thereof |
WO2022251280A1 (en) * | 2021-05-25 | 2022-12-01 | Vividion Therapeutics, Inc. | Compounds selective for jak1 and methods of use |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5549974A (en) * | 1994-06-23 | 1996-08-27 | Affymax Technologies Nv | Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof |
US6001579A (en) * | 1993-10-01 | 1999-12-14 | The Trustees Of Columbia University | Supports and combinatorial chemical libraries thereof encoded by non-sequencable tags |
Family Cites Families (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3255196A (en) | 1966-06-07 | Phenoxyalkyl piperidine derivatives | ||
CA696999A (en) | 1964-11-03 | Ayerst, Mckenna And Harrison | Therapeutic compounds and their preparation | |
GB1052302A (en) * | 1963-04-22 | |||
GB1055548A (en) | 1965-08-23 | 1967-01-18 | Acraf | New substituted 1-aryl-3-aminopropynes and process for their preparation |
US3632767A (en) | 1968-02-12 | 1972-01-04 | Mallinckrodt Chemical Works | Treatment of depression with 4-substituted piperidines |
US3686187A (en) * | 1970-05-25 | 1972-08-22 | Abbott Lab | 4-anilino-1-(4-p-fluorophenyl-1-butyl) piperidine compounds |
AR206937A1 (en) * | 1974-09-06 | 1976-08-31 | Lilly Co Eli | PROCEDURE FOR PREPARING 1-SUBSTITUTE-4-ALKYL-4-PHENYL-PIPERIDINE COMPOUNDS |
DE2651574A1 (en) | 1976-11-12 | 1978-05-18 | Boehringer Mannheim Gmbh | 3-Phenoxymethyl-piperidino 1-heterocyclyl-oxo-propane derivs. - useful as vasodilators and beta adrenergic receptor inhibitors |
US4312876A (en) * | 1979-02-23 | 1982-01-26 | Hoechst-Roussel Pharmaceuticals Incorporated | Antidepressive and analgesic 4-aryloxy- and 4-arylthio-3-phenylpiperidines |
GB2056435A (en) * | 1979-06-26 | 1981-03-18 | Ciba Geigy Ag | Novel Tetrahydropyridine and Piperidine Substituted Benzofuranes and Related Compounds |
DE2939292A1 (en) | 1979-09-28 | 1981-04-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | N-PHENOXYALKYLPIPERIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS |
PH17194A (en) * | 1980-03-06 | 1984-06-19 | Otsuka Pharma Co Ltd | Novel carbostyril derivatives,and pharmaceutical composition containing the same |
US4577020A (en) * | 1983-01-25 | 1986-03-18 | The Upjohn Company | Aminoalkyl and aminoalkenyl triazoles as anti-psychotic agents |
ZA848275B (en) * | 1983-12-28 | 1985-08-28 | Degussa | New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring |
DE3421641A1 (en) * | 1984-06-09 | 1985-12-12 | Merck Patent Gmbh, 6100 Darmstadt | INDOLDER DERIVATIVES |
JPS61115068A (en) | 1984-11-08 | 1986-06-02 | Hokuriku Seiyaku Co Ltd | 4-benzylpiperidinylpropoxyaniline derivative |
US4567186A (en) * | 1985-01-14 | 1986-01-28 | Sterling Drug Inc. | 5-Heteryl-1,6-naphthyridin-2(1H)-ones, cardiotonic use thereof and intermediates therefor |
JPH0615529B2 (en) | 1985-04-01 | 1994-03-02 | エーザイ株式会社 | Novel piperidine derivative |
EP0228893A3 (en) | 1985-12-20 | 1990-01-03 | A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) | Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl group in allergy treatment |
DK623586A (en) | 1985-12-27 | 1987-06-28 | Eisai Co Ltd | PIPERIDE INGREDIENTS OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS |
KR910006138B1 (en) | 1986-09-30 | 1991-08-16 | 에자이 가부시끼가이샤 | Cyclic amine derivatives |
DE3703435A1 (en) | 1987-02-05 | 1988-08-18 | Thomae Gmbh Dr K | NEW THIAZOLES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
FR2620704B1 (en) | 1987-09-17 | 1991-04-26 | Sanofi Sa | (BENZYL-4 PIPERIDINO) -1 PROPANOL-2 DERIVATIVES, THEIR PREPARATION, THEIR USE AS ANTIMICROBIALS AND THE PRODUCTS CONTAINING THEM |
HUT58275A (en) | 1987-12-11 | 1992-02-28 | Mitsui Petrochemical Ind | Process for producing amines and pharmaceutical compositions containing them |
ZA891901B (en) | 1988-03-17 | 1989-11-29 | Merrell Dow Pharma | Method for the treatment of the extrapyramidal side effects associated with neuroleptic therapy |
FR2640266B2 (en) | 1988-07-12 | 1992-07-10 | Synthelabo | INDOLONES-2, QUINOLEINONES-2, BENZO (B) AZEPINONES-2 AND BENZIMIDAZOLONES-2 DERIVATIVES OF (HYDROXY-1 PIPERIDINYL-2 ALKYL), THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
US4902695A (en) | 1989-02-13 | 1990-02-20 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
US5011834A (en) | 1989-04-14 | 1991-04-30 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon | PCP receptor ligands and the use thereof |
ES2098248T3 (en) | 1989-05-17 | 1997-05-01 | Pfizer | DERIVATIVES OF 2-PIPERIDINE-1-ALCANOLS AS ANTI-ISCHEMICAL AGENTS. |
WO1991006297A1 (en) | 1989-10-27 | 1991-05-16 | The Du Pont Merck Pharmaceutical Company | (n-phthalimidoalkyl) piperidines |
US5149817A (en) | 1990-03-05 | 1992-09-22 | Shionogi & Co., Ltd. | Teirahydropyridine derivatives |
US5169855A (en) | 1990-03-28 | 1992-12-08 | Du Pont Merck Pharmaceutical Company | Piperidine ether derivatives as psychotropic drugs or plant fungicides |
US5116846A (en) | 1990-03-28 | 1992-05-26 | Du Pont Merck Pharmaceutical Company | N-aralkyl piperidine derivatives as psychotropic drugs |
JPH0699423B2 (en) | 1990-05-10 | 1994-12-07 | フアイザー・インコーポレイテツド | Neuroprotective indolone and related derivatives |
JPH04217945A (en) | 1990-07-18 | 1992-08-07 | Zeria Pharmaceut Co Ltd | Substituted alkylbenzene derivative and antitumor agent containing the same derivative |
MX9100513A (en) | 1990-08-06 | 1992-04-01 | Smith Kline French Lab | COMPOUNDS |
FR2668149B1 (en) | 1990-10-18 | 1994-09-23 | Synthelabo | 1- (3,4-DIHYDRO-2-OXO-1H-QUINOLEIN-6-YL) -2- [4- (2-PHENYL-ETHYL) PIPERIDIN-1-YL] ETHANOL, ITS PREPARATION AND THERAPEUTIC APPLICATION . |
US5273977A (en) * | 1990-11-05 | 1993-12-28 | Warner-Lambert Company | Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
US5270312A (en) * | 1990-11-05 | 1993-12-14 | Warner-Lambert Company | Substituted piperazines as central nervous system agents |
EP0488959A3 (en) | 1990-11-28 | 1992-08-05 | Sandoz Ltd. | New uses of competitive nmda receptor antagonists |
JPH04312572A (en) | 1991-04-12 | 1992-11-04 | Takeda Chem Ind Ltd | Cyclic amine compound |
US5231099A (en) | 1991-04-15 | 1993-07-27 | Du Pont Merck Pharmaceutical Company | Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs |
EP0591426A4 (en) | 1991-06-27 | 1996-08-21 | Univ Virginia Commonwealth | Sigma receptor ligands and the use thereof |
EP0524846A1 (en) | 1991-06-27 | 1993-01-27 | Synthelabo | 2-(Piperidin-1-yl)ethanol derivatives, their preparation and their use in therapeutics |
AU655840B2 (en) | 1991-07-17 | 1995-01-12 | Pfizer Inc. | 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents |
FR2681319B1 (en) | 1991-09-12 | 1995-02-17 | Synthelabo | 1- (PHENOXYALKYL) PIPERIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION. |
HU211019B (en) | 1991-12-02 | 1995-09-28 | Richter Gedeon Vegyeszet | Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds |
JPH07503461A (en) | 1992-01-28 | 1995-04-13 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | Compounds as calcium channel antagonists |
US5202346A (en) | 1992-02-25 | 1993-04-13 | American Home Products Corporation | Piperidinyl and piperazinyl derivatives |
ES2060547B1 (en) | 1992-06-04 | 1995-06-16 | Ferrer Int | IMPROVEMENTS IN THE PURPOSE OF THE INVENTION PATENT N / 9201158 THAT REFERS TO "PROCEDURE FOR OBTAINING NEW DERIVATIVES OF 4-BENCILPIPERIDINE". |
US5192751A (en) | 1992-07-24 | 1993-03-09 | Eli Lilly And Company | Use of competitive NMDA receptor antagonists in the treatment of urinary incontinence |
PL173618B1 (en) | 1992-10-30 | 1998-04-30 | Pfizer | Neuroprotective 3,4-dihydro-2(1h)-quinolonic compounds |
US5922773A (en) | 1992-12-04 | 1999-07-13 | The Children's Medical Center Corp. | Glaucoma treatment |
WO1994018172A1 (en) | 1993-02-01 | 1994-08-18 | Yoshitomi Pharmaceutical Industries, Ltd. | Imidazolylbenzene compound and use thereof as medicine |
US5352683A (en) | 1993-03-05 | 1994-10-04 | Virginia Commonwealth University Medical College Of Virginia | Method for the treatment of chronic pain |
TW281670B (en) | 1993-09-02 | 1996-07-21 | Hoffmann La Roche | |
DE4335718A1 (en) | 1993-10-20 | 1995-04-27 | Merck Patent Gmbh | Cyclic amine derivatives |
DE4410822A1 (en) | 1994-03-24 | 1995-09-28 | Schering Ag | New piperidine derivatives |
ZA9610738B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | Subtype selective nmda receptor ligands and the use thereof |
-
1996
- 1996-12-19 ZA ZA9610741A patent/ZA9610741B/en unknown
- 1996-12-20 US US09/091,594 patent/US6130234A/en not_active Expired - Fee Related
- 1996-12-20 NZ NZ325735A patent/NZ325735A/en unknown
- 1996-12-20 DE DE69628035T patent/DE69628035T2/en not_active Expired - Fee Related
- 1996-12-20 EA EA199800591A patent/EA001133B1/en not_active IP Right Cessation
- 1996-12-20 SK SK823-98A patent/SK82398A3/en unknown
- 1996-12-20 ES ES96944537T patent/ES2196196T3/en not_active Expired - Lifetime
- 1996-12-20 CA CA002240038A patent/CA2240038A1/en not_active Abandoned
- 1996-12-20 CZ CZ981778A patent/CZ177898A3/en unknown
- 1996-12-20 PL PL96327413A patent/PL327413A1/en unknown
- 1996-12-20 EP EP96944537A patent/EP0869791B1/en not_active Expired - Lifetime
- 1996-12-20 DK DK96944537T patent/DK0869791T3/en active
- 1996-12-20 AU AU14310/97A patent/AU719430B2/en not_active Ceased
- 1996-12-20 JP JP09523881A patent/JP2000502352A/en not_active Ceased
- 1996-12-20 IL IL12506096A patent/IL125060A/en not_active IP Right Cessation
- 1996-12-20 PT PT96944537T patent/PT869791E/en unknown
- 1996-12-20 BR BR9612153-0A patent/BR9612153A/en not_active Application Discontinuation
- 1996-12-20 AT AT96944537T patent/ATE239473T1/en not_active IP Right Cessation
- 1996-12-20 WO PCT/US1996/020766 patent/WO1997023214A1/en not_active Application Discontinuation
-
1998
- 1998-06-19 BG BG102561A patent/BG63424B1/en unknown
- 1998-06-19 MX MX9805032A patent/MX9805032A/en not_active IP Right Cessation
- 1998-06-19 NO NO19982869A patent/NO312028B1/en unknown
-
2000
- 2000-06-13 US US09/592,883 patent/US6448270B1/en not_active Expired - Fee Related
-
2002
- 2002-07-29 US US10/206,578 patent/US20030105133A1/en not_active Abandoned
- 2002-08-06 US US10/172,525 patent/US20030100018A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6001579A (en) * | 1993-10-01 | 1999-12-14 | The Trustees Of Columbia University | Supports and combinatorial chemical libraries thereof encoded by non-sequencable tags |
US5549974A (en) * | 1994-06-23 | 1996-08-27 | Affymax Technologies Nv | Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050069916A1 (en) * | 2000-08-11 | 2005-03-31 | Chait Brian T. | Ultra-sensitive detection systems |
US20030124595A1 (en) * | 2001-11-06 | 2003-07-03 | Lizardi Paul M. | Sensitive coded detection systems |
US20070207555A1 (en) * | 2005-02-03 | 2007-09-06 | Cesar Guerra | Ultra-sensitive detection systems using multidimension signals |
US20160327543A1 (en) * | 2014-01-02 | 2016-11-10 | John P. Jasper | Method for continuously monitoring chemical or biological processes |
Also Published As
Publication number | Publication date |
---|---|
EA001133B1 (en) | 2000-10-30 |
US6448270B1 (en) | 2002-09-10 |
IL125060A0 (en) | 1999-01-26 |
PT869791E (en) | 2003-08-29 |
PL327413A1 (en) | 1998-12-07 |
WO1997023214A1 (en) | 1997-07-03 |
JP2000502352A (en) | 2000-02-29 |
SK82398A3 (en) | 1999-03-12 |
EP0869791A4 (en) | 1999-04-28 |
AU1431097A (en) | 1997-07-17 |
US6130234A (en) | 2000-10-10 |
DK0869791T3 (en) | 2003-06-10 |
DE69628035D1 (en) | 2003-06-12 |
BG102561A (en) | 1999-04-30 |
EA199800591A1 (en) | 1999-02-25 |
NO312028B1 (en) | 2002-03-04 |
CA2240038A1 (en) | 1997-07-03 |
BR9612153A (en) | 1999-12-28 |
ATE239473T1 (en) | 2003-05-15 |
MX9805032A (en) | 1998-11-30 |
ZA9610741B (en) | 1997-06-24 |
NZ325735A (en) | 2000-02-28 |
EP0869791B1 (en) | 2003-05-07 |
NO982869L (en) | 1998-08-24 |
DE69628035T2 (en) | 2004-02-12 |
US20030105133A1 (en) | 2003-06-05 |
EP0869791A1 (en) | 1998-10-14 |
AU719430B2 (en) | 2000-05-11 |
IL125060A (en) | 2003-07-31 |
NO982869D0 (en) | 1998-06-19 |
ES2196196T3 (en) | 2003-12-16 |
CZ177898A3 (en) | 1998-12-16 |
BG63424B1 (en) | 2002-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6475807B1 (en) | Mass-based encoding and qualitative analysis of combinatorial libraries | |
US20030100018A1 (en) | Mass-based encoding and qualitative analysis of combinatorial libraries | |
Geysen et al. | Isotope or mass encoding of combinatorial libraries | |
Carell et al. | New promise in combinatorial chemistry: synthesis, characterization, and screening of small-molecule libraries in solution | |
EP0879219B1 (en) | Attached tags for use in combinatorial chemistry synthesis | |
Jacobs et al. | Combinatorial chemistry—applications of light-directed chemical synthesis | |
Mario Geysen et al. | Combinatorial compound libraries for drug discovery: an ongoing challenge | |
CA2187792A1 (en) | Complex combinatorial chemical libraries encoded with tags | |
WO1998011036A9 (en) | Attached tags for use in combinatorial chemistry synthesis | |
Czarnik | Peer Reviewed: Combinatorial Chemistry | |
Frank | High-density synthetic peptide microarrays: emerging tools for functional genomics and proteomics | |
Miertus et al. | Combinatorial chemistry and technologies: methods and applications | |
WO2002099078A2 (en) | Functional proteomic profiling | |
Rasheed et al. | Combinatorial chemistry: a review | |
EP3384041B1 (en) | Method for identification of protease substrates | |
JPH11513027A (en) | Compound | |
Fauchère et al. | Combinatorial chemistry for the generation of molecular diversity and the discovery of bioactive leads | |
EP1119528B1 (en) | Chemical constructs and their uses | |
Ede et al. | Beyond Rf tagging | |
Simon et al. | Using peptoid libraries [oligo N-substituted glycines] for drug discovery | |
Berk et al. | Spatially arrayed mixture (SPAM) technology: Synthesis of two-dimensionally indexed orthogonal combinatorial libraries | |
Wintner et al. | Combinatorial libraries in solution: polyfunctionalized core molecules | |
Xiao et al. | Radiofrequency encoding and additional techniques for the structure elucidation of synthetic combinatorial libraries | |
Crooks et al. | Overview of combinatorial chemistry | |
Aberhart | Using Stable Isotopes to Solve Problems in Combinatorial Chemistry |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |